N-ABLE, INC., 10-Q filed on 11/5/2026
Quarterly Report
v3.26.3
Cover Page - shares
 9 Months Ended
Sep. 30, 2026
Nov. 02, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2026  
Document Transition Report false  
Entity File Number 001-40297  
Entity Registrant Name N-able, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 85-4069861  
Entity Address, Address Line One 30 Corporate Drive  
Entity Address, Address Line Two Suite 400  
Entity Address, City or Town Burlington  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 01803  
City Area Code 781  
Local Phone Number 328-6490  
Title of 12(b) Security Common Stock, $0.001 par value  
Trading Symbol NABL  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   176,719,518
Entity Central Index Key 0001834488  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q3  
Amendment Flag false  
v3.26.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 92,480 $ 111,837
Accounts receivable, net of allowances of $3,879 and $4,059 as of September 30, 2026 and December 31, 2025, respectively 45,155 49,972
Income tax receivable 3,194 3,432
Recoverable taxes 6,426 9,807
Current contract assets 16,092 19,528
Prepaid and other current assets 23,781 21,494
Total current assets 187,128 216,070
Property and equipment, net 43,051 38,392
Operating lease right-of-use assets 33,892 28,666
Deferred taxes 1,769 4,164
Goodwill 1,010,761 1,024,300
Intangible assets, net 53,353 64,786
Other assets, net 33,378 33,340
Total assets 1,363,332 1,409,718
Current liabilities:    
Accounts payable 12,307 8,999
Accrued liabilities and other 49,027 55,283
Current contingent consideration 0 10,840
Current deferred consideration 65,704 60,720
Current operating lease liabilities 6,941 7,203
Income taxes payable 9,351 9,986
Current portion of deferred revenue 20,468 27,207
Current debt obligation 5,176 4,000
Total current liabilities 168,974 184,238
Long-term liabilities:    
Deferred revenue, net of current portion 443 1,747
Non-current deferred taxes 1,720 1,847
Non-current operating lease liabilities 34,309 29,284
Long-term debt, net of current portion 387,557 389,873
Other long-term liabilities 2,067 685
Total liabilities 595,070 607,674
Commitments and contingencies (Note 11)
Stockholders’ equity:    
Common stock, $0.001 par value: 550,000,000 shares authorized, 193,280,796 and 190,459,837 shares issued, and 179,319,903 and 186,683,682 shares outstanding as of September 30, 2026 and December 31, 2025, respectively 193 190
Preferred stock, $0.001 par value: 50,000,000 shares authorized and no shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively 0 0
Treasury stock, at cost: 13,960,893 and 3,776,155 shares as of September 30, 2026 and December 31, 2025, respectively (68,690) (30,000)
Additional paid-in capital 772,745 746,599
Accumulated other comprehensive income 15,569 32,514
Retained earnings 48,445 52,741
Total stockholders' equity 768,262 802,044
Total liabilities and stockholders' equity $ 1,363,332 $ 1,409,718
Treasury stock, common (in shares) 13,960,893 3,776,155
v3.26.3
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Allowance on accounts receivable $ 3,879 $ 4,059
Common stock, par or stated value per share (in dollars per share) $ 0.001 $ 0.001
Common stock, authorized (in shares) 550,000,000 550,000,000
Common stock, shares issued (in shares) 193,280,796 190,459,837
Common stock outstanding (in shares) 179,319,903 186,683,682
Preferred stock, par or stated value per share (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 50,000,000 50,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Treasury stock, common (in shares) 13,960,893 3,776,155
v3.26.3
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue:        
Subscription and other revenue $ 137,451 $ 131,058 $ 408,043 $ 379,667
Cost of revenue:        
Cost of revenue 30,322 25,490 85,708 73,598
Amortization of acquired technologies 4,232 4,240 12,710 12,636
Total cost of revenue 34,554 29,730 98,418 86,234
Gross profit 102,897 101,328 309,625 293,433
Operating expenses:        
Sales and marketing 39,073 40,488 124,345 123,254
Research and development 27,006 25,188 79,771 75,408
General and administrative 20,756 24,288 60,919 71,425
Amortization of acquired intangibles 663 497 1,656 1,499
Total operating expenses 87,498 90,461 266,691 271,586
Operating income 15,399 10,867 42,934 21,847
Other expense, net:        
Interest expense, net (8,057) (8,631) (23,989) (23,792)
Other (expense) income, net 183 4,950 (913) 5,643
Total other expense, net (7,874) (3,681) (24,902) (18,149)
Income before income taxes 7,525 7,186 18,032 3,698
Income tax expense 11,898 6,272 22,328 14,636
Net income (loss) $ (4,373) $ 914 $ (4,296) $ (10,938)
Net income (loss) per share:        
Basic income (loss) per share (in dollars per share) $ (0.02) $ 0.00 $ (0.02) $ (0.06)
Diluted income (loss) per share (in dollars per share) $ (0.02) $ 0.00 $ (0.02) $ (0.06)
Weighted-average shares used to compute net income (loss) per share:        
Shares used in computation of basic income (loss) per share (in shares) 186,087 187,599 187,408 188,213
Shares used in computation of diluted income (loss) per share (in shares) 186,087 188,420 187,408 188,213
v3.26.3
Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Statement of Comprehensive Income [Abstract]        
Net (loss) income $ (4,373) $ 914 $ (4,296) $ (10,938)
Other comprehensive (loss) income:        
Foreign currency translation adjustment (2,100) 1,175 (16,945) 53,827
Other comprehensive (loss) income (2,100) 1,175 (16,945) 53,827
Comprehensive (loss) income $ (6,473) $ 2,089 $ (21,241) $ 42,889
v3.26.3
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Retained Earnings
Balance at beginning of period (in shares) at Dec. 31, 2024   187,529,000        
Balance at beginning of period at Dec. 31, 2024 $ 759,556 $ 187 $ 0 $ 708,992 $ (21,179) $ 71,556
Beginning balance (in shares) at Dec. 31, 2024     0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (10,938)         (10,938)
Foreign currency translation adjustment 53,827       53,827  
Restricted stock units issued, net of shares withheld for taxes (in shares)   2,154,000        
Restricted stock units issued, net of shares withheld for taxes (11,508) $ 3   (11,511)    
Issuance of stock (in shares)   102,000        
Issuance of stock 1,107     1,107    
Issuance of stock under employee stock purchase plan (in shares)   321,000        
Issuance of stock under employee stock plans 2,360     2,360    
Repurchase of stock (in shares)     (2,487,000)      
Repurchase of common stock (20,000)   $ (20,000)      
Stock-based compensation 37,009     37,009    
Balance at end of period (in shares) at Sep. 30, 2025   190,106,000        
Balance at end of period at Sep. 30, 2025 811,413 $ 190 $ (20,000) 737,957 32,648 60,618
Ending balance (in shares) at Sep. 30, 2025     (2,487,000)      
Balance at beginning of period (in shares) at Jun. 30, 2025   189,559,000        
Balance at beginning of period at Jun. 30, 2025 807,937 $ 190 $ (10,000) 726,570 31,473 59,704
Beginning balance (in shares) at Jun. 30, 2025     (1,250,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income 914         914
Foreign currency translation adjustment 1,175       1,175  
Restricted stock units issued, net of shares withheld for taxes (in shares)   385,000        
Restricted stock units issued, net of shares withheld for taxes (1,741) $ 0   (1,741)    
Issuance of stock (in shares)   0        
Issuance of stock 0     0    
Issuance of stock under employee stock purchase plan (in shares)   162,000        
Issuance of stock under employee stock plans 1,062     1,062    
Repurchase of stock (in shares)     (1,237,000)      
Repurchase of common stock (10,000)   $ (10,000)      
Stock-based compensation 12,066     12,066    
Balance at end of period (in shares) at Sep. 30, 2025   190,106,000        
Balance at end of period at Sep. 30, 2025 $ 811,413 $ 190 $ (20,000) 737,957 32,648 60,618
Ending balance (in shares) at Sep. 30, 2025     (2,487,000)      
Balance at beginning of period (in shares) at Dec. 31, 2025 186,683,682 190,460,000        
Balance at beginning of period at Dec. 31, 2025 $ 802,044 $ 190 $ (30,000) 746,599 32,514 52,741
Beginning balance (in shares) at Dec. 31, 2025 (3,776,155)   (3,776,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income $ (4,296)         (4,296)
Foreign currency translation adjustment (16,945)       (16,945)  
Restricted stock units issued, net of shares withheld for taxes (in shares)   2,316,000        
Restricted stock units issued, net of shares withheld for taxes (6,137) $ 3   (6,140)    
Issuance of stock 0          
Issuance of stock under employee stock purchase plan (in shares)   505,000        
Issuance of stock under employee stock plans 1,824     1,824    
Repurchase of stock (in shares)     (10,185,000)      
Repurchase of common stock (38,691)   $ (38,690) (1)    
Stock-based compensation $ 30,463     30,463    
Balance at end of period (in shares) at Sep. 30, 2026 179,319,903 193,281,000        
Balance at end of period at Sep. 30, 2026 $ 768,262 $ 193 $ (68,690) 772,745 15,569 48,445
Ending balance (in shares) at Sep. 30, 2026 (13,960,893)   (13,961,000)      
Balance at beginning of period (in shares) at Jun. 30, 2026   192,682,000        
Balance at beginning of period at Jun. 30, 2026 $ 804,628 $ 193 $ (30,000) 763,948 17,669 52,818
Beginning balance (in shares) at Jun. 30, 2026     (3,776,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net (loss) income (4,373)         (4,373)
Foreign currency translation adjustment (2,100)       (2,100)  
Restricted stock units issued, net of shares withheld for taxes (in shares)   372,000        
Restricted stock units issued, net of shares withheld for taxes (765)     (765)    
Issuance of stock 0          
Issuance of stock under employee stock purchase plan (in shares)   227,000        
Issuance of stock under employee stock plans 647     647    
Repurchase of stock (in shares)     (10,185,000)      
Repurchase of common stock (38,691)   $ (38,690) (1)    
Stock-based compensation $ 8,916     8,916    
Balance at end of period (in shares) at Sep. 30, 2026 179,319,903 193,281,000        
Balance at end of period at Sep. 30, 2026 $ 768,262 $ 193 $ (68,690) $ 772,745 $ 15,569 $ 48,445
Ending balance (in shares) at Sep. 30, 2026 (13,960,893)   (13,961,000)      
v3.26.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net (loss) income $ (4,296) $ (10,938)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization 32,927 32,572
(Benefit from) provision for doubtful accounts (180) 2,442
Stock-based compensation expense 29,996 36,434
Loss (gain) on asset disposal 36 (319)
Deferred taxes 2,215 96
Amortization of debt issuance costs and discounts 684 1,180
Loss (gain) on foreign currency exchange rates 2,967 (2,619)
(Gain) loss on contingent consideration (303) 3,498
Deferred consideration expense 4,984 11,414
Loss (gain) on lease modification 110 (441)
Other non-cash expenses 2 521
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in business combinations:    
Accounts receivable 5,159 (2,381)
Income taxes receivable 222 (206)
Recoverable taxes 3,200 16,915
Current contract assets 3,436 (9,909)
Operating lease right-of-use assets, net (1,753) (671)
Prepaid expenses and other current assets 1,333 (6,534)
Accounts payable 3,039 1,269
Accrued liabilities and other (5,015) (1,214)
Income taxes payable (462) 442
Deferred revenue (8,206) (4,273)
Other long-term assets 1,307 417
Other long-term liabilities 1,383 171
Net cash provided by operating activities 72,785 67,866
Cash flows from investing activities    
Purchases of property and equipment (18,070) (13,656)
Purchases of intangible assets and other (7,746) (8,642)
Return of deposits in escrow 0 299
Acquisitions (3,000) 0
Net cash used in investing activities (28,816) (21,999)
Cash flows from financing activities    
Payments of tax withholding obligations related to restricted stock units (6,140) (11,511)
Proceeds from issuance of common stock under employee stock plans 1,824 2,360
Repurchase of common stock (37,781) (20,000)
Deferred acquisition payments (10,537) (5,358)
Repayments of debt (3,254) (2,625)
Payments of debt issuance costs (2,298) 0
Net cash used in financing activities (58,186) (37,134)
Effect of exchange rate changes on cash and cash equivalents (5,140) 7,506
Net (decrease) increase in cash and cash equivalents (19,357) 16,239
Cash and cash equivalents    
Beginning of period 111,837 85,196
End of period 92,480 101,435
Supplemental disclosure of cash flow information    
Cash paid for interest 20,138 18,966
Cash paid for income taxes 16,923 11,554
Supplemental disclosure of non-cash activities:    
Change in purchases of property, equipment and leasehold improvements included in accounts payable and accrued expenses (9) 786
Right-of-use assets obtained in exchange for operating lease liabilities 11,024 5,580
Unsettled repurchases of common stock included in accrued liabilities and other 909 0
Insurance premiums financed 1,430 0
Assets acquired in exchange for vendor credits $ 7 $ 319
v3.26.3
Organization and Nature of Operations
 9 Months Ended
Sep. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Nature of Operations Organization and Nature of Operations
Description of Business
N-able, Inc., a Delaware corporation, together with its subsidiaries, protects businesses from evolving cyberthreats. Our AI-powered cybersecurity platform delivers business resilience to over 500,000 organizations worldwide, leveraging advanced end-to-end capabilities, simplified workflows, market-leading integrations, and flexible deployment options to improve efficiency and drive critical security outcomes. Our partner-first approach pairs our technology with experts, training, and peer-led events that empower customers to be secure, resilient, and successful.
v3.26.3
Summary of Significant Accounting Policies
 9 Months Ended
Sep. 30, 2026
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
The Company’s significant accounting policies are disclosed in the audited consolidated financial statements for the year ended December 31, 2025, and notes thereto, which are included in the Company’s Annual Report on Form 10-K that was filed with the Securities and Exchange Commission on February 26, 2026, as amended by Amendment No. 1 on Form 10-K/A filed with the Securities and Exchange Commission on August 10, 2026. Since the date of those financial statements, there have been no material changes to the Company’s significant accounting policies, except as described below.
Basis of Presentation
Our interim Consolidated Financial Statements do not include all of the information and footnotes required by United States of America generally accepted accounting principles (“GAAP”) for complete financial statements. The interim financial information is unaudited, but reflects all normal recurring adjustments that are, in our opinion, necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2025, as amended by Amendment No. 1 on Form 10-K/A, referred to together as our “2025 Annual Report.”
Revision of Previously Issued Financial Statements
During the three months ended June 30, 2026, we identified errors related to (i) the net overstatement of revenue associated with certain subscription arrangements and (ii) the accounting for vendor credits on server infrastructure trade-ins, resulting in errors in other income and depreciation expense. Also, we had other immaterial errors from prior periods, including certain balance sheet accounts originating from our 2021 separation from SolarWinds, primarily related to the calculation of foreign exchange. We assessed these errors individually and in the aggregate and concluded they were not material to any previously issued annual or interim consolidated financial statements. However, in accordance with Staff Accounting Bulletin No. 108 of the Securities and Exchange Commission (“SEC”), the Company concluded that correcting the cumulative errors in the three months ended June 30, 2026 would have been material to its statement of operations for the three and six months ended June 30, 2026. As a result, we revised our previously issued financial statements.
Additionally, in conjunction with the revision, the Company corrected certain other immaterial items that were previously corrected out of period and that were previously identified and concluded as immaterial, individually and in the aggregate, to its financial statements.
The revised amounts as of and for the three and nine months ended September 30, 2025 are reflected in the accompanying Consolidated Financial Statements and related footnotes. The Consolidated Balance Sheet as of December 31, 2025 reflects the revised amounts previously reported in our 2025 Annual Report. In addition, the amounts presented for the nine months ended September 30, 2026 in the accompanying Consolidated Financial Statements reflect the correction of the errors attributable to the six months ended June 30, 2026.
For the three and nine months ended September 30, 2025 and the nine months ended September 30, 2026, revisions to the Consolidated Statements of Stockholders’ Equity are limited to changes in net loss and foreign currency translation adjustments, and the resulting impact to accumulated other comprehensive (loss) income, retained earnings, and total stockholders’ equity. These revisions align to the revised Consolidated Balance Sheets and Consolidated Statements of Operations and Comprehensive Income presented below. Amounts presented herein for prior periods, including in the applicable notes to the Consolidated Financial Statements, reflect the revision.
Consolidated Balance Sheet
(In thousands)
September 30, 2025
As Previously ReportedAdjustmentsAs Revised
Assets
Current assets:
Accounts receivable, net of allowance of $3,328 as of September 30, 2025
44,947 (370)44,577 
Current contract assets22,836 47 22,883 
Total current assets200,346 (323)200,023 
Property and equipment, net38,989 505 39,494 
Total assets$1,398,052 $182 $1,398,234 
Liabilities and stockholders' equity
Current liabilities:
Accrued liabilities and other49,997 (473)49,524 
Income taxes payable10,118 969 11,087 
Current portion of deferred revenue17,100 1,659 18,759 
Total current liabilities158,362 2,155 160,517 
Long-term liabilities:
Total liabilities584,666 2,155 586,821 
Commitments and contingencies (Note 11)
Stockholders’ equity:
Accumulated other comprehensive income33,836 (1,188)32,648 
Retained earnings61,403 (785)60,618 
Total stockholders' equity813,386 (1,973)811,413 
Total liabilities and stockholders' equity$1,398,052 $182 $1,398,234 
Consolidated Statements of Operations and Comprehensive Income
(In thousands, except per share information)
Three Months Ended September 30, 2025Nine Months Ended September 30, 2025
As Previously ReportedAdjustmentsAs RevisedAs Previously ReportedAdjustmentsAs Revised
Revenue:
Subscription and other revenue$131,710 $(652)$131,058 $381,156 $(1,489)$379,667 
Cost of revenue:
Cost of revenue25,409 81 25,490 73,388 210 73,598 
Total cost of revenue29,649 81 29,730 86,024 210 86,234 
Gross profit102,061 (733)101,328 295,132 (1,699)293,433 
Total operating expenses90,461 — 90,461 271,586 — 271,586 
Operating income11,600 (733)10,867 23,546 (1,699)21,847 
Other expense, net:
Other income, net4,793 157 4,950 5,324 319 5,643 
Total other expense, net(3,838)157 (3,681)(18,468)319 (18,149)
Income (loss) before income taxes7,762 (576)7,186 5,078 (1,380)3,698 
Income tax expense6,379 (107)6,272 14,879 (243)14,636 
Net income (loss)$1,383 $(469)$914 $(9,801)$(1,137)$(10,938)
Other comprehensive income:
Foreign currency translation adjustment1,199 (24)1,175 54,931 (1,104)53,827 
Other comprehensive income1,199 (24)1,175 54,931 (1,104)53,827 
Comprehensive income$2,582 $(493)$2,089 $45,130 $(2,241)$42,889 
Net income (loss) per share:
Basic income (loss) per share$0.01 $(0.00)$0.00 $(0.05)$(0.01)$(0.06)
Diluted income (loss) per share$0.01 $(0.00)$0.00 $(0.05)$(0.01)$(0.06)

Consolidated Statements of Cash Flows
(In thousands)
Nine Months Ended September 30, 2025
As Previously ReportedAdjustmentsAs Revised
Cash flows from operating activities
Net loss$(9,801)$(1,137)$(10,938)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization32,362 210 32,572 
Gain on asset disposal— (319)(319)
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in business combinations:
Current contract assets(10,050)141 (9,909)
Income taxes payable685 (243)442 
Deferred revenue(5,621)1,348 (4,273)
Net cash provided by operating activities67,866 — 67,866 
Use of Estimates
The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. The actual results that we experience may differ materially from our estimates. The accounting estimates that require our most significant, difficult and subjective judgments include:
•the valuation of goodwill, intangibles, and long-lived assets;
•the valuation of contingent consideration;
•revenue recognition; and
•income taxes.
Money Market Fund Financial Assets
As of September 30, 2026 and December 31, 2025, we have money market fund financial assets of $47.1 million and $68.2 million, respectively, which are included in “cash and cash equivalents” in our Consolidated Balance Sheets. See “Fair Value Measurements” below and Note 6. Fair Value Measurements for further details regarding the fair value measurements of our money market fund financial assets.
Fair Value Measurements
We apply the authoritative guidance on fair value measurements for financial assets and liabilities, such as our money market fund financial assets and contingent consideration liabilities, that are measured at fair value on a recurring basis and non-financial assets and liabilities, such as goodwill, intangible assets and property, plant and equipment that are measured at fair value on a non-recurring basis.
The guidance establishes a three-tiered fair value hierarchy that prioritizes inputs to valuation techniques used in fair value calculations. The three levels of inputs are defined as follows:
Level 1: Unadjusted quoted prices for identical assets or liabilities in active markets accessible by us.
Level 2: Inputs that are observable in the marketplace other than those inputs classified as Level 1.
Level 3: Inputs that are unobservable in the marketplace and significant to the valuation.
The carrying values reported in our Consolidated Balance Sheets for cash, accounts receivable, accounts payable and other accrued expenses approximate fair value due to relatively short periods to maturity. See Note 6. Fair Value Measurements for a summary of our financial instruments accounted for at fair value on a recurring basis as of September 30, 2026 and December 31, 2025. As of September 30, 2026 and December 31, 2025, the carrying value of our outstanding debt under the Credit Agreement approximates its estimated fair value as the interest rate on the debt is adjusted for changes in market rates. As of September 30, 2026, the carrying value of our insurance premium financing approximates its fair value due to its short-term nature. See Note 8. Debt for further details regarding our debt.
Debt
The Company accounts for debt instruments in accordance with ASC 470, Debt. Debt is initially recorded at the amount of cash proceeds received, adjusted for debt discounts, premiums, and issuance costs, and is subsequently measured at amortized cost using the effective interest method. Debt is classified as current or noncurrent based on the contractual maturity date and the absence or presence of conditions that would require repayment within twelve months of the balance sheet date.
The Company’s financing arrangements may include non-revolving delayed draw debt commitments. Fees paid in connection with obtaining such commitments are deferred and recorded as a loan commitment asset, which represents the Company’s contractual right to access future financing. The loan commitment asset is initially measured at its incurred cost and is assessed for impairment at each reporting period. Upon the funding of a delayed draw term loan, the Company derecognizes the associated portion of the loan commitment asset and records it as a discount to the funded debt, which is amortized to interest expense over the term of the related loan using the effective interest method. If it becomes probable that all or a portion of the loan commitment will not be drawn, the related portion of the loan commitment asset is expensed immediately.
Goodwill
Goodwill represents the excess of the consideration transferred over the estimated fair value of the identifiable net assets acquired in a business combination. Goodwill is not amortized and is tested for impairment at least annually during the fourth quarter, or more frequently if events or changes in circumstances indicate that the carrying value of the reporting unit may exceed its fair value. We operate as a single reporting unit for purposes of goodwill impairment testing. An impairment charge is recognized for the amount by which the reporting unit’s carrying value exceeds its fair value, limited to the amount of goodwill allocated to the reporting unit.
We estimate the fair value of our single reporting unit using a market approach based on the Company’s market capitalization, as adjusted for an appropriate control premium. We operate as a single reporting unit and our common stock is actively traded in an observable market, and we therefore concluded that our market capitalization, as adjusted for a control premium, provides the most representative indication of the fair value of the reporting unit.
In applying the market approach, we believe a market participant buyer would generally be willing to pay a premium above the quoted market price of our common stock to obtain a controlling interest in the business. The control premium is derived from control premiums observed in comparable market transactions and is compared to the implied control premium based upon estimated synergies that would be realized by a hypothetical buyer. The selection of an appropriate control premium requires judgment and represents a key assumption used in estimating the fair value of the reporting unit. See Note 4. Goodwill for further information regarding our evaluation of potential indicators of impairment during the three months ended September 30, 2026.
Asset Acquisitions
We evaluate each acquisition to determine whether the acquired set of assets and activities meets the definition of a business. If substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, the set is not a business and the transaction is accounted for as an asset acquisition. In an asset acquisition, the cost of the acquisition, including direct transaction costs, is allocated to the assets acquired and liabilities assumed on a relative fair value basis, and no goodwill is recognized. Contingent consideration in an asset acquisition that is not required to be accounted for as a derivative is recognized when payment becomes probable and the amount can be reasonably estimated, with a corresponding increase to the cost of the acquired assets. Any such increase is amortized over the remaining useful life of the related asset. See Note 3. Acquisitions for further details regarding our July 2026 asset acquisition.
Restructuring
Restructuring costs consist primarily of severance and other employee termination benefits. We account for one-time termination benefits in accordance with ASC 420, Exit or Disposal Cost Obligations, and recognize a liability at fair value when the plan of termination has been approved by management, communicated to affected employees, and the other recognition criteria have been met. If affected employees are required to render service beyond a minimum retention period to receive the termination benefits, the liability is recognized ratably over the future service period. Other costs associated with exit activities are recognized when incurred. Restructuring liabilities are included in “accrued liabilities and other” in our Consolidated Balance Sheets, are reviewed each reporting period, and adjusted for changes in estimates. See Note 13. Restructuring for further details regarding our workforce reorganization during the three months ended September 30, 2026.
Accumulated Other Comprehensive Income
Changes in accumulated other comprehensive income by component are summarized below:
Foreign Currency Translation AdjustmentsAccumulated Other Comprehensive Income
(in thousands)
Balance as of December 31, 2025$32,514 $32,514 
Other comprehensive loss before reclassification(16,945)(16,945)
Amount reclassified from accumulated other comprehensive income— — 
Net current period other comprehensive loss(16,945)(16,945)
Balance as of September 30, 2026$15,569 $15,569 
Revenue
Our revenue consists of the following:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(in thousands)
Subscription revenue$136,343 $129,865 $404,567 $375,751 
Other revenue1,108 1,193 3,476 3,916 
Total subscription and other revenue$137,451 $131,058 $408,043 $379,667 
During the three and nine months ended September 30, 2026 and 2025, respectively, we recognized the following revenue from subscription and other services at a point in time and over time:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(in thousands)
Revenue recognized at a point in time$8,886 $13,071 $28,544 $39,902 
Revenue recognized over time128,565 117,987 379,499 339,765 
Total revenue recognized$137,451 $131,058 $408,043 $379,667 

Deferred Revenue
Deferred revenue primarily consists of transaction prices allocated to remaining performance obligations from annually billed subscription agreements and maintenance services associated with our historical sales of perpetual license products which are delivered over time. Certain of our maintenance agreements are billed annually in advance or one-time for services to be performed over a 12-month period. We initially record the amounts allocated to maintenance performance obligations as deferred revenue and recognize these amounts ratably on a daily basis over the term of the maintenance agreement.
The following table reflects the changes in our total deferred revenue balance for the nine months ended September 30, 2026:
Total Deferred Revenue
(in thousands)
Balance as of December 31, 2025$28,954 
Deferred revenue recognized(26,641)
Additional amounts deferred18,598 
Balance as of September 30, 2026$20,911 
Contract Assets
Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. Contract assets primarily relate to unbilled amounts for contracts with customers for which the amount of revenue recognized exceeds the amount billed to the customer. Contract assets are transferred to accounts receivable when the right to invoice becomes unconditional. Contract assets are recorded as current if the invoice will be delivered to the customer within the succeeding 12-month period, with the remaining recorded as long-term. Current contract assets were $16.1 million and $19.5 million as of September 30, 2026 and December 31, 2025, respectively. Non-current contract assets were $0.6 million and $2.4 million as of September 30, 2026 and December 31, 2025, respectively, and are included in other non-current assets on our Consolidated Balance Sheets.
Capitalized Commissions
We recognize as an asset the incremental costs of obtaining a contract with a customer if we expect to recover those costs, and amortize the asset in accordance with the pattern of transfer of goods and services to which the asset relates. ASC 606 defines the incremental costs of obtaining a contract as the costs that an entity incurs in its efforts to obtain a contract that would not have been incurred if the contract had not been obtained.
We recognize the incremental costs of obtaining contracts as expense when incurred if the amortization period of the assets that we otherwise would have recognized is one year or less. For long-term committed contracts, we expect that commission fees paid to sales representatives as a result of obtaining these contracts are recoverable and are therefore capitalized. Current
capitalized commissions were $3.2 million and $2.7 million as of September 30, 2026 and December 31, 2025, respectively, and are included in “prepaid and other current assets” in our Consolidated Balance Sheets. Non-current capitalized commissions were $2.0 million and $2.3 million as of September 30, 2026 and December 31, 2025, respectively, and are included in “other non-current assets” in our Consolidated Balance Sheets. Capitalized commissions are amortized on a straight-line basis over a period of three years, and are included in “sales and marketing” in our Consolidated Statements of Operations. We recognized amortization of capitalized commissions of $0.8 million and $0.5 million during the three months ended September 30, 2026 and 2025, respectively. We recognized amortization of capitalized commissions of $2.2 million and $1.4 million during the nine months ended September 30, 2026 and 2025, respectively.
Remaining Performance Obligations
We expect to recognize revenue related to remaining performance obligations as of September 30, 2026, as follows:
Revenue Recognition Expected by Period
TotalLess than 1 year1-3 yearsMore than 3 years
(in thousands)
Expected recognition of remaining performance obligations$267,169 $200,371 $66,371 $427 

Cost of Revenue
Amortization of Acquired Technologies. During the three and nine months ended September 30, 2026 and 2025, respectively, amortization of acquired technologies included in cost of revenue relate to our subscription products as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(in thousands)
Amortization of acquired technologies$4,232 $4,240 $12,710 $12,636 
Recently Adopted Accounting Pronouncements
In July 2025, the FASB issued ASU No. 2025-05, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets,” (“ASU No. 2025-05”) to introduce a practical expedient for the application of the current expected credit loss model to current accounts receivable and contract assets. The updated guidance is effective for public companies for fiscal years beginning after December 15, 2025 and early adoption is permitted. We adopted this standard as of January 1, 2026 and elected the practical expedient. The adoption of the standard did not have a material impact on our consolidated financial statements.
Recently Issued Accounting Pronouncements
In November 2024, the FASB issued ASU No. 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses,” which requires public companies to disclose, in interim and annual reporting periods, additional information about certain expenses in the financial statements. The updated guidance is effective for public companies for fiscal periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. We are currently evaluating the impact of this standard on our consolidated financial statements.
In September 2025, the FASB issued ASU No. 2025-06, “Targeted Improvements to the Accounting for Internal-Use Software.” The updated guidance is effective for public companies for fiscal years beginning after December 15, 2027 and early adoption is permitted. We are currently evaluating the impact of this standard on our consolidated financial statements.
v3.26.3
Acquisitions
 9 Months Ended
Sep. 30, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Acquisitions Acquisitions
Infrascale, Inc.
On July 29, 2026 (the “Closing Date”), N-able Technologies Ltd, a wholly owned subsidiary of the Company, entered into an Asset Purchase Agreement (the “APA”) with Infrascale, Inc. (“Infrascale”) and acquired certain customer contracts, customer lists, and related contract rights (the “Acquired Contracts”). We did not acquire Infrascale’s software, source code, or employees. Under the APA, we received a perpetual, non-exclusive, non-transferable, royalty-free license to distribute the Infrascale backup products solely to the customers party to the Acquired Contracts (the “Acquired Customers”), and we intend
to migrate the Acquired Customers to our Cove data protection solution. Because substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset, we accounted for the transaction as an asset acquisition rather than a business combination, and no goodwill was recognized.
Consideration consists of $3.0 million in cash paid at closing and contingent consideration based on Converted ARR (as defined in the APA), measured quarterly over the 36 months following the Closing Date. Contingent payments are equal to 100% of Converted ARR in excess of $3.0 million up to $6.0 million, plus 125% of any Converted ARR in excess of $6.0 million.
Contingent consideration is recognized when payment becomes probable and the amount can be reasonably estimated, with a corresponding increase to the cost of the acquired intangible asset. As of September 30, 2026, we concluded that payment of contingent consideration was not probable, and accordingly no liability has been recorded. Future payments, if any, will depend on the number of Acquired Customers that migrate to our solutions and the resulting Converted ARR, and we are not able to reasonably estimate the amount of such payments at this time.
The total cost of the acquisition of $3.0 million was allocated to a single customer relationships intangible asset, which is being amortized on a straight-line basis over its estimated useful life of 36 months. No transaction costs were capitalized. We recognized $0.2 million of amortization expense related to this asset during the three and nine months ended September 30, 2026, which is included in amortization of acquired intangibles in our Consolidated Statements of Operations.
Adlumin, Inc.
On November 20, 2024, we acquired Adlumin, Inc. (“Adlumin”) a Washington, D.C. based enterprise-grade security operations platform provider. The aggregate consideration payable at closing of the transaction included $98.7 million in cash and the issuance of up to 1,570,762 shares of our common stock. Additionally, the former Adlumin shareholders have the right to receive $120.0 million in cash in installments of $52.5 million and $67.5 million on the first and second anniversaries of the closing date, respectively, and up to an aggregate of $30.0 million in potential cash earn-out payments payable in 2025 and 2026 based upon the achievement of certain performance metrics against defined targets for the 2024 and 2025 fiscal years.
The following table summarizes the amounts recognized for the assets acquired and liabilities assumed:
(in thousands)
Current liabilities, net, including cash acquired of $52
$(9,071)
Property and equipment, net182 
Non-current liabilities, net(4,754)
Identifiable intangible assets
Developed technology74,800 
Customer relationships5,400 
Trademarks300 
Goodwill160,498 
Total assets acquired, net$227,355 
The results of operations related to Adlumin since the acquisition date are included in our Consolidated Financial Statements. Of the $120.0 million of deferred consideration, $7.0 million and $7.8 million are contingent upon certain employees’ continued employment on the first and second anniversaries of the closing date, respectively. The amounts associated with continued employment are accounted for as compensation expense for post-combination services. During the year ended December 31, 2025, we paid $6.2 million of such amounts in connection with the first anniversary of the closing date. Of the remaining $105.2 million of deferred consideration, $45.5 million and $59.7 million are required to be paid on the first and second anniversary dates of the closing, respectively, based upon the passage of time and were recorded at fair value as of the date of the transaction. During the year ended December 31, 2025, we paid $45.5 million of such amounts in connection with the first anniversary of the closing date.
At the date of acquisition, the fair value of the deferred consideration was $96.3 million. As of September 30, 2026, the fair value of the deferred consideration, net of payments of $51.7 million, was $65.7 million, resulting in the recognition of expense of $1.7 million and $5.0 million for the three and nine months ended September 30, 2026, respectively. We recognized $0.9 million and $2.6 million in general and administrative expense related to the service-based portion of deferred consideration, and $0.8 million and $2.4 million in interest expense related to the time-based portion of the deferred consideration, for the three and nine months ended September 30, 2026, respectively.
At the date of acquisition, the fair value of the contingent consideration was $16.6 million. The earn-out arrangement provided for up to $15.0 million in potential cash payments for each of the 2024 and 2025 fiscal years, based upon the achievement of certain performance metrics against defined targets. In June 2025, we made a cash earn-out payment of
$5.4 million related to the 2024 fiscal year performance metrics. During the three months ended June 30, 2026, we made a cash earn-out payment of $10.5 million related to the 2025 fiscal year performance metrics, which was the second and final cash earn-out payment. Immediately prior to this payment, the fair value of the remaining contingent consideration was $10.5 million, resulting in the recognition of a gain of $0.3 million for the nine months ended September 30, 2026. As of September 30, 2026, the contingent consideration has been paid in full.
See Note 6. Fair Value Measurements, Note 7. Accrued Liabilities and Other and Note 11. Commitments and Contingencies for additional information regarding the deferred and contingent consideration liabilities.
We recognize revenue on the acquired products in accordance with our revenue recognition policy as described in Note 2. Summary of Significant Accounting Policies.
v3.26.3
Goodwill
 9 Months Ended
Sep. 30, 2026
Intangible Asset, Goodwill and Other [Abstract]  
Goodwill Goodwill
The following table reflects the changes in goodwill for the nine months ended September 30, 2026:
(in thousands)
Balance as of December 31, 2025$1,024,300 
Acquisitions— 
Foreign currency translation and other adjustments(13,539)
Balance as of September 30, 2026$1,010,761 
A significant portion of our assets consists of goodwill, which represents the excess of the purchase price over the estimated fair value of net assets acquired in business combinations and was primarily derived from the take‑private transaction of SolarWinds in February 2016 and subsequent acquisitions. We test goodwill for impairment at least annually during the fourth quarter and more frequently if events or changes in circumstances indicate that an impairment may exist. An impairment is recognized when the carrying value of our reporting unit exceeds its estimated fair value. No goodwill impairment has been recorded during the nine months ended September 30, 2026 and 2025.
We operate as a single reporting unit for purposes of goodwill impairment testing. During the three months ended June 30, 2026, we identified indicators of potential impairment, primarily due to a sustained decline in our stock price and market capitalization, and performed an interim quantitative goodwill impairment test as of June 30, 2026. The fair value of our reporting unit exceeded its carrying value and, therefore, no goodwill impairment was recorded during the three months ended June 30, 2026.
During the three months ended September 30, 2026, we evaluated indicators of impairment for our single reporting unit, including an increase in our stock price, and determined that it was more likely than not that the fair value of our reporting unit exceeded its carrying value. As a result, Management concluded that a triggering event did not occur during the three months ended September 30, 2026 and a quantitative impairment test of goodwill was not required during the period.
A sustained decline in the Company's stock price, or changes in other assumptions used in estimating the fair value of the reporting unit, could indicate that the fair value of the reporting unit has declined below its carrying value and could require the recognition of a goodwill impairment charge in a future period, which could have a material adverse impact on the Company's results of operations. The Company will continue to monitor its stock price and other relevant qualitative and quantitative factors throughout the remainder of fiscal 2026, including in connection with our annual goodwill impairment test in the fourth quarter.
v3.26.3
Relationship with Parent and Related Entities
 9 Months Ended
Sep. 30, 2026
Related Party Transactions [Abstract]  
Relationship with Parent and Related Entities Relationship with Parent and Related Entities
On August 6, 2020, SolarWinds Corporation (“SolarWinds” or “Parent”) announced that its board of directors had authorized management to explore a potential spin-off of its MSP business into our company, a newly created and separately traded public company, and separate into two distinct, publicly traded companies (the “Separation”). On July 19, 2021, SolarWinds completed the Separation through a pro-rata distribution (the “Distribution”) of all the outstanding shares of our common stock it held to the stockholders of record of SolarWinds as of the close of business on July 12, 2021. As a result of the
Distribution, we became an independent public company and our common stock is listed under the symbol “NABL” on the New York Stock Exchange.
Equity-Based Incentive Plans
Prior to the Separation and Distribution, certain of our employees participated in Parent’s equity-based incentive plans. Under the SolarWinds Corporation 2016 Equity Incentive Plan (the “2016 Plan”), our employees, consultants, directors, managers and advisors were awarded stock-based incentive awards in a number of forms, including non-qualified stock options. The ability to grant any future equity awards under the 2016 Plan terminated in October 2018. Under the SolarWinds Corporation 2018 Equity Incentive Plan, our employees were eligible to be awarded stock-based incentive awards, including non-statutory stock options or incentive stock options, stock appreciation rights, restricted stock, restricted stock units, performance stock units and other cash-based or share-based awards. Awards granted to our employees under the Parent incentive plans generally vested over periods ranging from one to five years. We measure stock-based compensation for all stock-based incentive awards at fair value on the grant date. Stock-based compensation expense is generally recognized on a straight-line basis over the requisite service periods of the awards.
In connection with the Separation and Distribution, all of the vested and outstanding and unvested SolarWinds equity awards held by our employees were converted to N-able awards (the “Conversion”). The modification of these equity awards resulted in incremental compensation expense to the extent the estimated fair value of the awards immediately following the modification exceeded the estimated fair value of the awards immediately prior to the modification. This expense is to be recognized upfront for all vested and outstanding awards and over the remaining vesting term for all unvested awards. We recognized no incremental expense in connection with the Conversion during each of the three months ended September 30, 2026 and 2025. We recognized no incremental expense in connection with the Conversion during the nine months ended September 30, 2026, and less than $0.1 million of incremental expense during the nine months ended September 30, 2025. We include stock-based compensation expense in operating expense (general and administrative, sales and marketing and research and development) and cost of revenue on our Consolidated Statements of Operations, depending on the nature of the employee’s role in our operations.
Agreements with SolarWinds
In connection with the completion of the Separation and Distribution on July 19, 2021, we entered into several agreements with SolarWinds that, among other things, provide a framework for our relationship with SolarWinds after the Separation and Distribution. The following summarizes some of the most significant agreements and relationships with SolarWinds.
Separation and Distribution Agreement
The Separation and Distribution Agreement sets forth our agreements with SolarWinds regarding the principal actions taken in connection with the Separation and Distribution. It also sets forth other agreements that govern aspects of our relationship with SolarWinds following the Separation and Distribution, including (i) the manner in which legal matters and claims are allocated and certain liabilities are shared between N-able and SolarWinds; (ii) other matters including transfers of assets and liabilities, treatment or termination of intercompany arrangements and the settlement or extinguishment of certain liabilities and other obligations between N-able and SolarWinds; and (iii) mutual indemnification clauses. The term of the Separation and Distribution Agreement is indefinite and it may only be terminated with the prior written consent of both N-able and SolarWinds.
Tax Matters Agreement
We entered into a Tax Matters Agreement with SolarWinds that governs the parties’ respective rights, responsibilities and obligations with respect to tax liabilities and benefits, tax attributes, the preparation and filing of tax returns, the control of audits and other tax proceedings and other matters regarding taxes. No costs were incurred under the Tax Matters Agreement during each of the three and nine months ended September 30, 2026 and 2025.
Software OEM Agreements
We entered into Software OEM Agreements with SolarWinds pursuant to which SolarWinds granted to N-able, and N-able granted to SolarWinds, a non-exclusive and royalty-bearing license to market, advertise, distribute and sublicense certain SolarWinds and N-able software products, respectively, to customers on a worldwide basis. Each agreement had a two-year term, and each agreement was renewed for additional two-year terms during each of the years ended December 31, 2023 and December 31, 2025. We earned $0.6 million of revenue during each of the three months ended September 30, 2026 and 2025, respectively, and incurred no costs and less than $0.1 million of costs during the three months ended September 30, 2026 and 2025, respectively, under the Software OEM Agreements. We earned $1.6 million and $1.5 million of revenue during the nine months ended September 30, 2026 and 2025, respectively, and incurred less than $0.1 million and $0.2 million of costs during the nine months ended September 30, 2026 and 2025, respectively, under the Software OEM Agreements.
Employee Matters Agreement
We entered into an Employee Matters Agreement with SolarWinds that governs N-able's and SolarWinds’ compensation and employee benefit obligations with respect to the employees and other service providers of each company, and generally allocated liabilities and responsibilities relating to employment matters and employee compensation and benefit plans and programs. No costs were incurred under the Employee Matters Agreement during the three and nine months ended September 30, 2026 and 2025.
Intellectual Property Matters Agreement
We entered into an Intellectual Property Matters Agreement with SolarWinds pursuant to which each party granted to the other party a generally irrevocable, non-exclusive, worldwide, and royalty-free license to use certain intellectual property rights retained by the other party. Under the Intellectual Property Matters Agreement, the term for the licensed or sublicensed know-how is perpetual and the term for each licensed or sublicensed patent is until expiration of the last valid claim of such patent. The Intellectual Property Matters Agreement will terminate only if N-able and SolarWinds agree in writing to terminate it. No costs were incurred under the Intellectual Property Matters Agreement during the three and nine months ended September 30, 2026 and 2025.
Trademark License Agreement
We entered into a Trademark License Agreement with SolarWinds pursuant to which SolarWinds granted to N-able a generally limited, worldwide, non-exclusive and royalty-free license to use certain trademarks retained by SolarWinds that were used by SolarWinds in the conduct of its business prior to the Separation and Distribution. The Trademark License Agreement will terminate once we cease to use all of the licensed trademarks. No costs were incurred under the Trademark License Agreement during the three and nine months ended September 30, 2026 and 2025.
Software Cross License Agreement
We entered into a Software Cross License Agreement with SolarWinds pursuant to which each party granted to the other party a generally perpetual, irrevocable, non-exclusive, worldwide and, subject to certain exceptions, royalty-free license to certain software libraries and internal tools for limited uses. The term of the Software Cross License Agreement will be perpetual unless N-able and SolarWinds agree in writing to terminate the agreement. Under the Software Cross License Agreement, we earned no revenue during each of the three and nine months ended September 30, 2026 and 2025, and incurred no costs during each of the three and nine months ended September 30, 2026 and 2025.
Sublease Agreement
We entered into a Sublease Agreement with SolarWinds for our office space in Austin, Texas. As of September 30, 2026, we do not occupy this subleased space. The Sublease Agreement is set to expire on November 30, 2026. We incurred operating lease costs of $0.2 million under the Sublease Agreement during each of the three months ended September 30, 2026 and 2025, respectively. We incurred operating lease costs of $0.5 million under the Sublease Agreement during each of the nine months ended September 30, 2026 and 2025, respectively.
v3.26.3
Fair Value Measurements
 9 Months Ended
Sep. 30, 2026
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The following tables summarize the fair value of our money market fund financial assets and contingent consideration financial liabilities that were measured on a recurring basis as of September 30, 2026 and December 31, 2025. See Note 3. Acquisitions and Note 11. Commitments and Contingencies for further details regarding our contingent consideration liabilities. There have been no transfers between fair value measurement levels during the three and nine months ended September 30, 2026 and 2025.
Fair Value Measurements as of
September 30, 2026 Using
Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)Total
(in thousands)
Assets:
Money market funds$47,145 $— $— $47,145 
Liabilities:
Contingent consideration$— $— $— $— 
Fair Value Measurements as of
December 31, 2025 Using
Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)Total
(in thousands)
Assets:
Money market funds$68,205 $— $— $68,205 
Liabilities:
Contingent consideration$— $— $10,840 $10,840 
The following table presents a summary of the changes in the fair value of our contingent consideration liabilities measured using Level 3 inputs during the three and nine months ended September 30, 2026 and 2025:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(in thousands)
Beginning balance$— $10,310 $10,840 $14,050 
Payments— — (10,537)(5,358)
Net (gains) losses recognized— 1,880 (303)3,498 
Ending balance$— $12,190 $— $12,190 
As of September 30, 2026 and December 31, 2025, the carrying value of our outstanding debt under the Credit Agreement approximates its estimated fair value as the interest rate on the debt is adjusted for changes in market rates. As of September 30, 2026, the carrying value of our insurance premium financing approximates its fair value due to its short-term nature. See Note 8. Debt for further details regarding our debt.
v3.26.3
Accrued Liabilities and Other
 9 Months Ended
Sep. 30, 2026
Payables and Accruals [Abstract]  
Accrued Liabilities and Other Accrued Liabilities and Other
Accrued and other current liabilities were as follows:
September 30,December 31,
20262025
(in thousands)
Payroll-related accruals$21,001 $28,572 
Value-added and other tax5,040 7,857 
Purchasing accruals4,834 3,998 
Accrued interest expense2,900 2,659 
Accrued professional fees2,354 2,143 
Accrued royalties3,389 3,462 
Consideration payable in cash or equity— 120 
Accrued restructuring2,150 — 
Accrued other liabilities7,359 6,472 
Total accrued liabilities and other$49,027 $55,283 
Accrued Restructuring
See Note 13. Restructuring for further details regarding the restructuring liability included in “accrued liabilities and other” in our Consolidated Balance Sheets.
v3.26.3
Debt
 9 Months Ended
Sep. 30, 2026
Debt Disclosure [Abstract]  
Debt Debt
In connection with the Separation and Distribution, on July 19, 2021, certain subsidiaries of the Company, including N-able International Holdings I, LLC (as guarantor) and N-able International Holdings II, LLC (as borrower), entered into a credit agreement (the “Credit Agreement”) with JPMorgan Chase Bank, N.A. as administrative agent and collateral agent and the lenders from time to time party thereto. N-able International Holdings I, LLC is a holding company with no other operations,
cash flows, material assets or liabilities other than the equity interests in N-able International Holdings II, LLC. The Credit Agreement provides for $410.0 million of first lien secured credit facilities (the “Credit Facilities”), consisting of a $60.0 million revolving credit facility (the “Revolving Facility”), and a $350.0 million term loan facility (the “Term Loan”). On July 19, 2021, prior to the completion of the Distribution, the Company distributed approximately $16.5 million, representing a portion of the proceeds from the Term Loan, net of the repayment of related party debt due to SolarWinds Holdings, Inc., payment of intercompany trade payables, and fees and other transaction related costs, to SolarWinds. The Revolving Facility will primarily be available for general corporate purposes.
On June 26, 2023, the parties entered into Amendment No. 1 (“Amendment No. 1”) to the Credit Agreement. Amendment No. 1 amended the Credit Agreement to, among other things, replace the LIBOR-based rate included in the Credit Agreement with a SOFR-based rate, as an interest rate benchmark. Other than the foregoing, the material terms of the Credit Agreement described herein remain unchanged. The effective interest rate on our outstanding debt remained as a LIBOR-based rate until August 31, 2023, at which point it transitioned to a SOFR-based rate.
On November 26, 2025, the parties entered into Amendment No. 2 (“Amendment No. 2”) to the Credit Agreement. Amendment No. 2, among other things, (i) increased the aggregate principal amount under the Term Loan from $336.0 million to $400.0 million, (ii) extended the maturity of the Term Loan to November 26, 2032, (iii) extended the maturity of the $60.0 million Revolving Facility to November 26, 2030 and (iv) reduced the interest rate applicable to all borrowings under the Credit Facilities.
As of the date of Amendment No. 2, existing unamortized discount and debt issuance costs were $4.1 million. Following a lender-by-lender extinguishment assessment, a portion of these costs was expensed, with the remaining balance deferred. The Company also incurred new discount and debt issuance costs in connection with the refinancing, portions of which were deferred and are being amortized over the term of the Credit Facilities.
On June 16, 2026 (the “Effective Date”), the Company entered into Amendment No. 3 to the Credit Agreement (“Amendment No. 3”). Amendment No. 3 added a delayed draw term loan facility (the “Delayed Draw Term Loan Facility”) pursuant to which the Company may draw up to an additional $75.0 million under the Term Loan (the “Delayed Draw Term Loan(s)”). The Delayed Draw Term Loan Facility will be available for borrowing during a six-month availability period (the “Availability Period” or “Commitment Period”) following the Effective Date through December 16, 2026 (the “Expiration Date”) and may be used for general corporate purposes.
The Delayed Draw Term Loan Facility permits the Company to draw up to five times during the Availability Period. There is a minimum funding amount of $1.0 million per draw with additional increments of $0.1 million allowed beyond the minimum requirement. The Term Loan and funded Delayed Draw Term Loan (collectively, the “Term Loan” subject to the “Credit Agreement”) have the same terms and are treated as a single fungible class of term loan for all purposes under the Credit Agreement, as amended, except that interest on the Delayed Draw Term Loans will commence on the date of the applicable draw. As of September 30, 2026, there were no borrowings under the Delayed Draw Term Loan Facility.
In connection with the Delayed Draw Term Loan Facility, the Company recognized a loan commitment asset (the “Loan Commitment Asset”) at its incurred cost. The Loan Commitment Asset represents the Company’s contractual right to future financing and meets the definition of a financial asset. Because the Expiration Date is less than 12 months from September 30, 2026, the Loan Commitment Asset is classified as a current asset. Upon funding of the Delayed Draw Term Loans, the Company will derecognize the associated portion of the Loan Commitment Asset and record it as a discount to the funded debt, which is amortized to interest expense over the term of the related loan using the effective interest method. The balance of the Loan Commitment Asset is $2.3 million as of September 30, 2026.
The following table summarizes information relating to our outstanding debt as of September 30, 2026 and December 31, 2025:
As of September 30, 2026As of December 31, 2025
Amount OutstandingEffective RateAmount OutstandingEffective Rate
(in thousands, except interest rates)
Term loan facility$397,000 6.51 %$400,000 6.59 %
Revolving credit facility— — %— — %
Total principal amount397,000 400,000 
Unamortized discount and debt issuance costs(5,443)(6,127)
Total debt, net391,557 393,873 
Less: Current debt obligation(4,000)(4,000)
Long-term debt, net of current portion$387,557 $389,873 
Under the Credit Agreement, as amended, borrowings denominated in U.S. dollars under the Revolving Facility bear interest at a floating rate of an Adjusted SOFR rate (subject to a “floor” of 0.0%) for a specified interest period plus an applicable margin of 2.50%, subject to an increase to 2.75% if our first lien net leverage ratio exceeds 2.50 to 1.00. Borrowings denominated in Euros under the Revolving Facility bear interest at a floating rate of an Adjusted Euro Interbank Offered Rate (“EURIBOR”) rate (subject to a “floor” of 0.0%) for a specified interest period plus the applicable margin described above. Under the Credit Agreement, borrowings under the Term Loan bear interest at a floating rate of an Adjusted SOFR rate (subject to a “floor” of 0.0%) for a specified interest period plus an applicable margin of 2.75%, subject to a reduction to 2.50% if our first lien net leverage ratio is equal to or lower than 1.65 to 1.00 (the “Applicable Rate”).
In addition to paying interest on loans outstanding under the Revolving Facility, we are required to pay a commitment fee of 0.375% per annum in respect of unused commitments thereunder, subject to a reduction to 0.25% per annum based on our first lien net leverage ratio.
Pursuant to the terms of the Delayed Draw Term Loan Facility, ticking fees accrue at the Applicable Rate per annum on undrawn amounts during the Commitment Period and are expensed as incurred in interest expense. Interest expense will begin to accrue on funded amounts at the Applicable Rate on the date the Delayed Draw Term Loans are funded.
The Term Loan requires quarterly repayments equal to 0.25% of the original principal amount. The final maturity dates of the Revolving Facility and Term Loan are November 26, 2030 and November 26, 2032, respectively.
The Credit Agreement contains a number of covenants that, among other things, restrict, subject to certain exceptions, our ability to: incur additional indebtedness; create liens; engage in mergers or consolidations; sell or transfer assets; pay dividends and distributions or repurchase our capital stock; make investments, loans or advances; prepay certain junior indebtedness; engage in certain transactions with affiliates; and enter into negative pledge agreements. In addition, the Revolving Facility is subject to a financial covenant requiring compliance with a maximum first lien net leverage ratio of 7.50 to 1.00 at the end of each fiscal quarter, which will trigger when loans outstanding under the Revolving Facility exceed 40% of the aggregate commitments under the Revolving Facility. The Credit Agreement contains certain customary events of default, including, among others, failure to pay principal, interest or other amounts; inaccuracy of representations and warranties; violation of covenants; cross events of default; certain bankruptcy and insolvency events; certain ERISA events; certain undischarged judgments; and change of control.
As of September 30, 2026 and December 31, 2025, we were in compliance with all covenants of the Credit Agreement.
The following table summarizes the remaining future minimum principal payments under the Credit Agreement as of September 30, 2026:
(in thousands)
2026$1,000 
20274,000 
20284,000 
20294,000 
Thereafter384,000 
Total minimum principal payments$397,000 
Insurance Premium Financing
During the three months ended September 30, 2026, we entered into an agreement with a third-party financing company to finance $1.4 million of our annual insurance premiums for policies effective August 1, 2026. The amount financed bears interest at an annual rate of 6.25% and is payable in 11 equal monthly installments from September 2026 through July 2027. The financing company holds a security interest in the unearned premiums of the financed policies. As of September 30, 2026, the outstanding balance under the agreement was $1.2 million, which is included in “current debt obligation” in our Consolidated Balance Sheets. The agreement is separate from the Credit Agreement and is not included in the tables above. As a result, current debt obligation in our Consolidated Balance Sheets as of September 30, 2026 consists of $4.0 million of current debt obligation under the Credit Agreement and $1.2 million of insurance premium financing.
v3.26.3
Earnings Per Share
 9 Months Ended
Sep. 30, 2026
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
Basic and Diluted Earnings Per Share
A reconciliation of the number of shares in the calculation of basic and diluted earnings per share follows:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(in thousands)
Basic earnings per share
Numerator:
Net income (loss)$(4,373)$914 $(4,296)$(10,938)
Denominator:
Weighted-average common shares outstanding used in computing basic earnings per share186,087 187,599 187,408 188,213 
Basic earnings per share$(0.02)$0.00 $(0.02)$(0.06)
Diluted earnings per share
Numerator:
Net income (loss)$(4,373)$914 $(4,296)$(10,938)
Denominator:
Weighted-average shares used in computing basic earnings per share186,087 187,599 187,408 188,213 
Add dilutive impact of employee equity plans— 821 — — 
Weighted-average shares used in computing diluted earnings per share186,087 188,420 187,408 188,213 
Diluted earnings per share$(0.02)$0.00 $(0.02)$(0.06)
The dilutive impact of employee equity awards was not applicable to the calculation of diluted net income (loss) per share for the three months ended September 30, 2026 and the nine months ended September 30, 2026 and 2025, as the effect would have been anti-dilutive.
The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of the diluted net income per share attributable to common stockholders for the three months ended September 30, 2025, because their effect would have been anti-dilutive or for which the performance condition had not been met at the end of the period:
Three Months Ended September 30,
2025
(in thousands)
Restricted stock units8,055 
Total anti-dilutive shares8,055 
The calculation of diluted earnings per share requires us to make certain assumptions related to the use of proceeds that would be received upon the assumed exercise of stock options, purchase of restricted stock or proceeds from the employee stock purchase plan.
Share Repurchase Program
On March 11, 2025, our board of directors approved a share repurchase program (the “Repurchase Program”) authorizing the repurchase of up to $75.0 million of our common stock, par value $0.001 per share (the “Common Stock”). The timing and total amount of stock repurchases will depend upon business, economic, and market conditions, corporate and regulatory requirements, prevailing stock prices, and other considerations. The Repurchase Program has no expiration date, may be suspended or discontinued at any time without notice, and does not obligate the Company to acquire any specific dollar amount or numbers of shares of Common Stock. On August 26, 2026, our board of directors approved a $50.0 million increase to the Repurchase Program, increasing the total authorization to $125.0 million. Under the Repurchase Program, we repurchased 3,776,155 shares for $30.0 million during the year ended December 31, 2025. We repurchased 10,184,738 shares for $38.7 million during the three months ended September 30, 2026. As of September 30, 2026, $56.3 million remained available for repurchases under the Repurchase Program. See Part II - Item 2. Unregistered Sales of Equity Securities and Use of Proceeds for additional information on the Repurchase Program.
v3.26.3
Income Taxes
 9 Months Ended
Sep. 30, 2026
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
For the three months ended September 30, 2026 and 2025, we recorded income tax expense of $11.9 million and $6.3 million, respectively, resulting in an effective tax rate of 158.1% and 87.3%, respectively. The increase in the effective tax rate for the three months ended September 30, 2026 compared to the same period in 2025 was primarily due to increases in income taxes on income outside of the United States, including the additional tax impact from the Company’s internal restructuring of its intellectual property, and the amount of unbenefited loss in the United States. For the nine months ended September 30, 2026 and 2025, we recorded income tax expense of $22.3 million and $14.6 million, respectively, resulting in an effective tax rate of 123.8% and 395.8%, respectively. The decrease in effective tax rate for the nine months ended September 30, 2026 compared to the same period in 2025 was primarily due to the overall increase in year-to-date income, partially offset by an increase in income taxes on income outside of the United States and a decrease in the amount of unbenefited loss in the United States attributable to the Company’s internal restructuring of its intellectual property. As noted above and described below, the effective tax rates for the three and nine months ended September 30, 2026 reflect a discrete income tax expense of $6.7 million related to an intercompany transaction.
On July 4, 2025, the President signed into law H.R. 1, the “One Big Beautiful Bill Act” (“OBBBA”). Key income tax-related provisions of the OBBBA include the repeal of mandatory capitalization of domestic research and development expenditures under Internal Revenue Code (IRC) Section 174, extension of bonus depreciation, the restoration of an EBITDA-based interest limitation deduction, and revisions to international tax regimes. The overall financial statement impact of the OBBBA is not material.
During the three months ended September 30, 2026, the Company completed an intercompany transfer of certain intellectual property rights from a non-U.S. subsidiary to a U.S. subsidiary to better align its intellectual property ownership with its business operations. As a result of the transaction, the Company recognized $6.7 million of discrete income tax expense, consisting of $5.1 million related directly to the transfer of the intellectual property rights and $1.6 million related to an increase in the valuation allowance on certain foreign deferred tax assets. Moreover, as a result of this transfer, the U.S. subsidiary received a step-up in tax basis of the transferred intellectual property rights to their current fair market value under applicable law. As the Company has a valuation allowance recorded in the U.S., there was no income tax benefit recorded on the step-up in tax basis. The step-up in basis will be amortized over 15 years for tax purposes.
Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense. As of September 30, 2026, we did not have any accrued interest and penalties related to unrecognized tax benefits.
In 2021, the Organization for Economic Co-operation and Development ("OECD") released model rules for a global minimum tax known as Pillar Two. Under such rules, a minimum effective tax rate of 15% would apply to multinational companies with consolidated revenues above €750 million. Although we operate in one or more jurisdictions that have substantively enacted Pillar Two legislation, we have not exceeded the revenue threshold of €750 million, and as such, we do not expect to be subject to the Pillar Two rules in 2026.
We file U.S., state and foreign income tax returns in jurisdictions with varying statutes of limitations. The 2021 through 2025 tax years generally remain open and subject to examination by federal, state and foreign tax authorities. We are currently under examination by the IRS for the tax years 2013 through the period ending February 2016. A Form 870-AD was signed with the Internal Revenue Service on January 22, 2025 related to tax years 2013 through the period ending February 2016. During the three months ended March 31, 2021, we finalized a settlement agreement with the IRS for the tax years 2011 to 2012. We are currently under audit by the Massachusetts Department of Revenue for the 2015 through February 2016 tax years, and the Texas Comptroller for the 2015 through 2018 tax years. We are currently under audit by the Canada Revenue Agency (“CRA”) for the tax years 2021 and 2022.
v3.26.3
Commitments and Contingencies
 9 Months Ended
Sep. 30, 2026
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Legal Proceedings
From time to time, we have been and may be involved in various legal proceedings arising in our ordinary course of business. In the opinion of management, the resolution of any pending claims (either individually or in the aggregate) is not expected to have a material adverse impact on our Consolidated Financial Statements, cash flows or financial position. However, the outcome of disputes is inherently uncertain. Therefore, although management considers the likelihood of such an outcome to be remote, an unfavorable resolution of one or more matters could materially affect our future results of operations or cash flows, or both, in a particular period.
Commitments as a Result of Acquisitions
See Note 3. Acquisitions, Note 6. Fair Value Measurements, and Note 7. Accrued Liabilities and Other for further details regarding our deferred and contingent consideration liabilities related to the November 20, 2024 acquisition of Adlumin.
See Note 3. Acquisitions for further details regarding the contingent consideration arrangements related to our July 29, 2026 asset acquisition from Infrascale, for which no liability has been recorded as of September 30, 2026.
v3.26.3
Operating Segments and Geographic Information
 9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Operating Segments and Geographic Information Operating Segments and Geographic Information
Operating Segments
Our chief operating decision-maker (“CODM”) is our Chief Executive Officer. As our CODM, our Chief Executive Officer manages the business as a multi-product business that utilizes its model to deliver software products to customers regardless of their geography or IT environment. Operating results, including discrete financial information and profitability metrics, are reviewed at the consolidated entity level for purposes of making resource allocation decisions and for evaluating financial performance. Accordingly, we consider ourselves to be in a single operating and reportable segment structure.
As we operate in a single operating and reportable segment structure, our CODM assesses performance for the segment and decides how to allocate resources based on consolidated net income, as presented in our Consolidated Statements of Operations, among other metrics. Segment asset information is not reported to the CODM. Our CODM uses consolidated net income to assess performance for the segment by reviewing actual performance against internal forecasts and historical performance. Since we operate as one operating segment, financial segment information, including profit or loss, can be found in our Consolidated Financial Statements. While not presented separately within our Consolidated Financial Statements, our consolidated net income (loss) includes depreciation expense of $4.0 million and $4.8 million and amortization expense of $6.9 million and $6.4 million for the three months ended September 30, 2026 and 2025, respectively, and depreciation expense of $12.7 million and $13.7 million and amortization expense of $20.2 million and $18.8 million for the nine months ended September 30, 2026 and 2025, respectively.
Geographic Information
We base revenue by geography on the billing address of each customer. Other than the United States and the United Kingdom, no single country accounted for 10% or more of our total revenue for the three and nine months ended September 30, 2026 and 2025, respectively. The following tables set forth revenue by geographic area:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(in thousands)
Revenue
United States, country of domicile$66,523 $64,579 $197,459 $189,230 
United Kingdom14,478 13,405 42,592 38,743 
All other international56,450 53,074 167,992 151,694 
Total revenue$137,451 $131,058 $408,043 $379,667 
Other than the United States, Switzerland, and United Kingdom, no single country accounted for 10% or more of our total net long-lived assets as of September 30, 2026 and December 31, 2025, respectively. The following tables set forth net long-lived assets by geographic area:
September 30,December 31,
20262025
(in thousands)
Long-lived assets, net
United States, country of domicile$13,752 $11,686 
Switzerland11,430 12,265 
United Kingdom8,843 5,724 
All other international9,026 8,717 
Total long-lived assets, net$43,051 $38,392 
v3.26.3
Restructuring
 9 Months Ended
Sep. 30, 2026
Restructuring and Related Activities [Abstract]  
Restructuring Restructuring
On July 20, 2026, we approved a plan to reorganize our global workforce, reducing headcount by approximately 6%, as part of cost-reduction initiatives intended to align investments with highest priority opportunities, operate a streamlined organization, and drive high levels of productivity (the “2026 Reorganization”). We expect the 2026 Reorganization to be substantially complete by December 31, 2026.
We expect to incur total costs of approximately $5.0 million to $6.0 million in connection with the 2026 Reorganization, consisting of cash expenditures for severance and related employee benefit costs. During the three and nine months ended September 30, 2026, we recognized $4.9 million of severance and related employee benefit costs related to the 2026 Reorganization. Of these costs, $2.3 million, $2.2 million, $0.3 million, and $0.1 million are included in “sales and marketing,” “research and development,” “cost of revenue,” and “general and administrative,” respectively, in our Consolidated Statements of Operations.
The following table summarizes activity in our restructuring liability related to the 2026 Reorganization, which is included in “accrued liabilities and other” in our Consolidated Balance Sheets.
(in thousands)
Balance as of December 31, 2025$— 
Costs incurred and charged to expense4,866 
Cash payments(2,706)
Effect of foreign currency exchange rates(10)
Balance as of September 30, 2026$2,150 
v3.26.3
Subsequent Events
 9 Months Ended
Sep. 30, 2026
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
Delayed Draw Term Loan
In June 2026, we entered into Amendment No. 3 to the Credit Agreement, which added the Delayed Draw Term Loan Facility. On October 8, 2026, we borrowed the full $75.0 million available under the Delayed Draw Term Loan Facility and received net proceeds of $73.4 million, after the payment of $0.7 million of ticking fees and $0.9 million of commitment fees. The Delayed Draw Term Loans have the same maturity date and interest rate as the existing Term Loan and are treated as a single class of term loans with the existing Term Loan under the Credit Agreement. We intend to use the proceeds for general corporate purposes, share repurchases, and the deferred consideration payment in November 2026. See Note 8. Debt for further details regarding the Delayed Draw Term Loan Facility.
v3.26.3
Insider Trading Arrangements
 3 Months Ended
Sep. 30, 2026
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Kathleen Pai [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
During the three months ended September 30, 2026, one of the Company’s officers adopted the stock trading plans described below:
Name and TitleCharacter of Trading ArrangementDate AdoptedDuration of Trading ArrangementAggregate Number of Shares of Common Stock to be Sold Pursuant to Trading Arrangement
Kathleen Pai
EVP, Chief People Officer		Rule 10b5-1
Trading Arrangement		8/20/2026Until June 1, 2027149,487 
_________________
(1) Trading arrangements characterized as a “Rule 10b5-1 Trading Arrangement” are intended to satisfy the affirmative defense of Rule 10b5-1(c), as amended (the “Rule”) and only permits transactions upon expiration of the applicable mandatory cooling-off period under the Rule.
(2) The trading arrangement permits transactions through and including the earlier to occur of (a) the completion of all sales or (b) the date listed in the table.
Name Kathleen Pai
Title EVP, Chief People Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date 8/20/2026
Expiration Date 06/01/2027
Arrangement Duration 285 days
Aggregate Available 149,487
v3.26.3
Summary of Significant Accounting Policies (Policies)
 9 Months Ended
Sep. 30, 2026
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
Our interim Consolidated Financial Statements do not include all of the information and footnotes required by United States of America generally accepted accounting principles (“GAAP”) for complete financial statements. The interim financial information is unaudited, but reflects all normal recurring adjustments that are, in our opinion, necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2025, as amended by Amendment No. 1 on Form 10-K/A, referred to together as our “2025 Annual Report.”
Use of Estimates
Use of Estimates
The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. The actual results that we experience may differ materially from our estimates. The accounting estimates that require our most significant, difficult and subjective judgments include:
•the valuation of goodwill, intangibles, and long-lived assets;
•the valuation of contingent consideration;
•revenue recognition; and
•income taxes.
Money Market Fund Financial Assets
Money Market Fund Financial Assets
As of September 30, 2026 and December 31, 2025, we have money market fund financial assets of $47.1 million and $68.2 million, respectively, which are included in “cash and cash equivalents” in our Consolidated Balance Sheets. See “Fair Value Measurements” below and Note 6. Fair Value Measurements for further details regarding the fair value measurements of our money market fund financial assets.
Fair Value Measurements
Fair Value Measurements
We apply the authoritative guidance on fair value measurements for financial assets and liabilities, such as our money market fund financial assets and contingent consideration liabilities, that are measured at fair value on a recurring basis and non-financial assets and liabilities, such as goodwill, intangible assets and property, plant and equipment that are measured at fair value on a non-recurring basis.
The guidance establishes a three-tiered fair value hierarchy that prioritizes inputs to valuation techniques used in fair value calculations. The three levels of inputs are defined as follows:
Level 1: Unadjusted quoted prices for identical assets or liabilities in active markets accessible by us.
Level 2: Inputs that are observable in the marketplace other than those inputs classified as Level 1.
Level 3: Inputs that are unobservable in the marketplace and significant to the valuation.
The carrying values reported in our Consolidated Balance Sheets for cash, accounts receivable, accounts payable and other accrued expenses approximate fair value due to relatively short periods to maturity. See Note 6. Fair Value Measurements for a summary of our financial instruments accounted for at fair value on a recurring basis as of September 30, 2026 and December 31, 2025. As of September 30, 2026 and December 31, 2025, the carrying value of our outstanding debt under the Credit Agreement approximates its estimated fair value as the interest rate on the debt is adjusted for changes in market rates. As of September 30, 2026, the carrying value of our insurance premium financing approximates its fair value due to its short-term nature. See Note 8. Debt for further details regarding our debt.
Debt
Debt
The Company accounts for debt instruments in accordance with ASC 470, Debt. Debt is initially recorded at the amount of cash proceeds received, adjusted for debt discounts, premiums, and issuance costs, and is subsequently measured at amortized cost using the effective interest method. Debt is classified as current or noncurrent based on the contractual maturity date and the absence or presence of conditions that would require repayment within twelve months of the balance sheet date.
The Company’s financing arrangements may include non-revolving delayed draw debt commitments. Fees paid in connection with obtaining such commitments are deferred and recorded as a loan commitment asset, which represents the Company’s contractual right to access future financing. The loan commitment asset is initially measured at its incurred cost and is assessed for impairment at each reporting period. Upon the funding of a delayed draw term loan, the Company derecognizes the associated portion of the loan commitment asset and records it as a discount to the funded debt, which is amortized to interest expense over the term of the related loan using the effective interest method. If it becomes probable that all or a portion of the loan commitment will not be drawn, the related portion of the loan commitment asset is expensed immediately.
Goodwill
Goodwill
Goodwill represents the excess of the consideration transferred over the estimated fair value of the identifiable net assets acquired in a business combination. Goodwill is not amortized and is tested for impairment at least annually during the fourth quarter, or more frequently if events or changes in circumstances indicate that the carrying value of the reporting unit may exceed its fair value. We operate as a single reporting unit for purposes of goodwill impairment testing. An impairment charge is recognized for the amount by which the reporting unit’s carrying value exceeds its fair value, limited to the amount of goodwill allocated to the reporting unit.
We estimate the fair value of our single reporting unit using a market approach based on the Company’s market capitalization, as adjusted for an appropriate control premium. We operate as a single reporting unit and our common stock is actively traded in an observable market, and we therefore concluded that our market capitalization, as adjusted for a control premium, provides the most representative indication of the fair value of the reporting unit.
In applying the market approach, we believe a market participant buyer would generally be willing to pay a premium above the quoted market price of our common stock to obtain a controlling interest in the business. The control premium is derived from control premiums observed in comparable market transactions and is compared to the implied control premium based upon estimated synergies that would be realized by a hypothetical buyer. The selection of an appropriate control premium requires judgment and represents a key assumption used in estimating the fair value of the reporting unit. See Note 4. Goodwill for further information regarding our evaluation of potential indicators of impairment during the three months ended September 30, 2026.
Asset Acquisitions
Asset Acquisitions
We evaluate each acquisition to determine whether the acquired set of assets and activities meets the definition of a business. If substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, the set is not a business and the transaction is accounted for as an asset acquisition. In an asset acquisition, the cost of the acquisition, including direct transaction costs, is allocated to the assets acquired and liabilities assumed on a relative fair value basis, and no goodwill is recognized. Contingent consideration in an asset acquisition that is not required to be accounted for as a derivative is recognized when payment becomes probable and the amount can be reasonably estimated, with a corresponding increase to the cost of the acquired assets. Any such increase is amortized over the remaining useful life of the related asset. See Note 3. Acquisitions for further details regarding our July 2026 asset acquisition.
Restructuring
Restructuring
Restructuring costs consist primarily of severance and other employee termination benefits. We account for one-time termination benefits in accordance with ASC 420, Exit or Disposal Cost Obligations, and recognize a liability at fair value when the plan of termination has been approved by management, communicated to affected employees, and the other recognition criteria have been met. If affected employees are required to render service beyond a minimum retention period to receive the termination benefits, the liability is recognized ratably over the future service period. Other costs associated with exit activities are recognized when incurred. Restructuring liabilities are included in “accrued liabilities and other” in our Consolidated Balance Sheets, are reviewed each reporting period, and adjusted for changes in estimates. See Note 13. Restructuring for further details regarding our workforce reorganization during the three months ended September 30, 2026
Deferred Revenue, Contract Assets, Capitalized Commissions
Deferred Revenue
Deferred revenue primarily consists of transaction prices allocated to remaining performance obligations from annually billed subscription agreements and maintenance services associated with our historical sales of perpetual license products which are delivered over time. Certain of our maintenance agreements are billed annually in advance or one-time for services to be performed over a 12-month period. We initially record the amounts allocated to maintenance performance obligations as deferred revenue and recognize these amounts ratably on a daily basis over the term of the maintenance agreement.
Contract Assets
Timing may differ between the satisfaction of performance obligations and the invoicing and collection of amounts related to our contracts with customers. Contract assets primarily relate to unbilled amounts for contracts with customers for which the amount of revenue recognized exceeds the amount billed to the customer. Contract assets are transferred to accounts receivable when the right to invoice becomes unconditional. Contract assets are recorded as current if the invoice will be delivered to the customer within the succeeding 12-month period, with the remaining recorded as long-term.
Capitalized Commissions
We recognize as an asset the incremental costs of obtaining a contract with a customer if we expect to recover those costs, and amortize the asset in accordance with the pattern of transfer of goods and services to which the asset relates. ASC 606 defines the incremental costs of obtaining a contract as the costs that an entity incurs in its efforts to obtain a contract that would not have been incurred if the contract had not been obtained.
We recognize the incremental costs of obtaining contracts as expense when incurred if the amortization period of the assets that we otherwise would have recognized is one year or less. For long-term committed contracts, we expect that commission fees paid to sales representatives as a result of obtaining these contracts are recoverable and are therefore capitalized. Current
capitalized commissions were $3.2 million and $2.7 million as of September 30, 2026 and December 31, 2025, respectively, and are included in “prepaid and other current assets” in our Consolidated Balance Sheets. Non-current capitalized commissions were $2.0 million and $2.3 million as of September 30, 2026 and December 31, 2025, respectively, and are included in “other non-current assets” in our Consolidated Balance Sheets. Capitalized commissions are amortized on a straight-line basis over a period of three years, and are included in “sales and marketing” in our Consolidated Statements of Operations. We recognized amortization of capitalized commissions of $0.8 million and $0.5 million during the three months ended September 30, 2026 and 2025, respectively. We recognized amortization of capitalized commissions of $2.2 million and $1.4 million during the nine months ended September 30, 2026 and 2025, respectively.
Recently Adopted/Issued Accounting Pronouncements
Recently Adopted Accounting Pronouncements
In July 2025, the FASB issued ASU No. 2025-05, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets,” (“ASU No. 2025-05”) to introduce a practical expedient for the application of the current expected credit loss model to current accounts receivable and contract assets. The updated guidance is effective for public companies for fiscal years beginning after December 15, 2025 and early adoption is permitted. We adopted this standard as of January 1, 2026 and elected the practical expedient. The adoption of the standard did not have a material impact on our consolidated financial statements.
Recently Issued Accounting Pronouncements
In November 2024, the FASB issued ASU No. 2024-03, “Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses,” which requires public companies to disclose, in interim and annual reporting periods, additional information about certain expenses in the financial statements. The updated guidance is effective for public companies for fiscal periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. We are currently evaluating the impact of this standard on our consolidated financial statements.
In September 2025, the FASB issued ASU No. 2025-06, “Targeted Improvements to the Accounting for Internal-Use Software.” The updated guidance is effective for public companies for fiscal years beginning after December 15, 2027 and early adoption is permitted. We are currently evaluating the impact of this standard on our consolidated financial statements.
v3.26.3
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2026
Accounting Policies [Abstract]  
Schedule of Condensed Balance Sheet
Consolidated Balance Sheet
(In thousands)
September 30, 2025
As Previously ReportedAdjustmentsAs Revised
Assets
Current assets:
Accounts receivable, net of allowance of $3,328 as of September 30, 2025
44,947 (370)44,577 
Current contract assets22,836 47 22,883 
Total current assets200,346 (323)200,023 
Property and equipment, net38,989 505 39,494 
Total assets$1,398,052 $182 $1,398,234 
Liabilities and stockholders' equity
Current liabilities:
Accrued liabilities and other49,997 (473)49,524 
Income taxes payable10,118 969 11,087 
Current portion of deferred revenue17,100 1,659 18,759 
Total current liabilities158,362 2,155 160,517 
Long-term liabilities:
Total liabilities584,666 2,155 586,821 
Commitments and contingencies (Note 11)
Stockholders’ equity:
Accumulated other comprehensive income33,836 (1,188)32,648 
Retained earnings61,403 (785)60,618 
Total stockholders' equity813,386 (1,973)811,413 
Total liabilities and stockholders' equity$1,398,052 $182 $1,398,234 
Schedule of Condensed Statement of Comprehensive Income
Consolidated Statements of Operations and Comprehensive Income
(In thousands, except per share information)
Three Months Ended September 30, 2025Nine Months Ended September 30, 2025
As Previously ReportedAdjustmentsAs RevisedAs Previously ReportedAdjustmentsAs Revised
Revenue:
Subscription and other revenue$131,710 $(652)$131,058 $381,156 $(1,489)$379,667 
Cost of revenue:
Cost of revenue25,409 81 25,490 73,388 210 73,598 
Total cost of revenue29,649 81 29,730 86,024 210 86,234 
Gross profit102,061 (733)101,328 295,132 (1,699)293,433 
Total operating expenses90,461 — 90,461 271,586 — 271,586 
Operating income11,600 (733)10,867 23,546 (1,699)21,847 
Other expense, net:
Other income, net4,793 157 4,950 5,324 319 5,643 
Total other expense, net(3,838)157 (3,681)(18,468)319 (18,149)
Income (loss) before income taxes7,762 (576)7,186 5,078 (1,380)3,698 
Income tax expense6,379 (107)6,272 14,879 (243)14,636 
Net income (loss)$1,383 $(469)$914 $(9,801)$(1,137)$(10,938)
Other comprehensive income:
Foreign currency translation adjustment1,199 (24)1,175 54,931 (1,104)53,827 
Other comprehensive income1,199 (24)1,175 54,931 (1,104)53,827 
Comprehensive income$2,582 $(493)$2,089 $45,130 $(2,241)$42,889 
Net income (loss) per share:
Basic income (loss) per share$0.01 $(0.00)$0.00 $(0.05)$(0.01)$(0.06)
Diluted income (loss) per share$0.01 $(0.00)$0.00 $(0.05)$(0.01)$(0.06)
Schedule of Condensed Cash Flow Statement
Consolidated Statements of Cash Flows
(In thousands)
Nine Months Ended September 30, 2025
As Previously ReportedAdjustmentsAs Revised
Cash flows from operating activities
Net loss$(9,801)$(1,137)$(10,938)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization32,362 210 32,572 
Gain on asset disposal— (319)(319)
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in business combinations:
Current contract assets(10,050)141 (9,909)
Income taxes payable685 (243)442 
Deferred revenue(5,621)1,348 (4,273)
Net cash provided by operating activities67,866 — 67,866 
Schedule of Changes In Accumulated Other Comprehensive Income By Component
Changes in accumulated other comprehensive income by component are summarized below:
Foreign Currency Translation AdjustmentsAccumulated Other Comprehensive Income
(in thousands)
Balance as of December 31, 2025$32,514 $32,514 
Other comprehensive loss before reclassification(16,945)(16,945)
Amount reclassified from accumulated other comprehensive income— — 
Net current period other comprehensive loss(16,945)(16,945)
Balance as of September 30, 2026$15,569 $15,569 
Schedule of Disaggregation of Revenue
Our revenue consists of the following:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(in thousands)
Subscription revenue$136,343 $129,865 $404,567 $375,751 
Other revenue1,108 1,193 3,476 3,916 
Total subscription and other revenue$137,451 $131,058 $408,043 $379,667 
During the three and nine months ended September 30, 2026 and 2025, respectively, we recognized the following revenue from subscription and other services at a point in time and over time:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(in thousands)
Revenue recognized at a point in time$8,886 $13,071 $28,544 $39,902 
Revenue recognized over time128,565 117,987 379,499 339,765 
Total revenue recognized$137,451 $131,058 $408,043 $379,667 
Schedule of Details Of Total Deferred Revenue Balance
The following table reflects the changes in our total deferred revenue balance for the nine months ended September 30, 2026:
Total Deferred Revenue
(in thousands)
Balance as of December 31, 2025$28,954 
Deferred revenue recognized(26,641)
Additional amounts deferred18,598 
Balance as of September 30, 2026$20,911 
Schedule of Remaining Performance Obligations for Revenue Recognition
We expect to recognize revenue related to remaining performance obligations as of September 30, 2026, as follows:
Revenue Recognition Expected by Period
TotalLess than 1 year1-3 yearsMore than 3 years
(in thousands)
Expected recognition of remaining performance obligations$267,169 $200,371 $66,371 $427 
Schedule of Amortization of Acquired Technologies
Amortization of Acquired Technologies. During the three and nine months ended September 30, 2026 and 2025, respectively, amortization of acquired technologies included in cost of revenue relate to our subscription products as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(in thousands)
Amortization of acquired technologies$4,232 $4,240 $12,710 $12,636 
v3.26.3
Acquisitions (Tables)
 9 Months Ended
Sep. 30, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Schedule of Consideration Paid And Amounts Recognized for Assets Acquired And Liabilities Assumed
The following table summarizes the amounts recognized for the assets acquired and liabilities assumed:
(in thousands)
Current liabilities, net, including cash acquired of $52
$(9,071)
Property and equipment, net182 
Non-current liabilities, net(4,754)
Identifiable intangible assets
Developed technology74,800 
Customer relationships5,400 
Trademarks300 
Goodwill160,498 
Total assets acquired, net$227,355 
v3.26.3
Goodwill (Tables)
 9 Months Ended
Sep. 30, 2026
Intangible Asset, Goodwill and Other [Abstract]  
Schedule of goodwill
The following table reflects the changes in goodwill for the nine months ended September 30, 2026:
(in thousands)
Balance as of December 31, 2025$1,024,300 
Acquisitions— 
Foreign currency translation and other adjustments(13,539)
Balance as of September 30, 2026$1,010,761 
v3.26.3
Fair Value Measurements (Tables)
 9 Months Ended
Sep. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Financial Assets Measured on a Recurring Basis
The following tables summarize the fair value of our money market fund financial assets and contingent consideration financial liabilities that were measured on a recurring basis as of September 30, 2026 and December 31, 2025. See Note 3. Acquisitions and Note 11. Commitments and Contingencies for further details regarding our contingent consideration liabilities. There have been no transfers between fair value measurement levels during the three and nine months ended September 30, 2026 and 2025.
Fair Value Measurements as of
September 30, 2026 Using
Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)Total
(in thousands)
Assets:
Money market funds$47,145 $— $— $47,145 
Liabilities:
Contingent consideration$— $— $— $— 
Fair Value Measurements as of
December 31, 2025 Using
Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)Total
(in thousands)
Assets:
Money market funds$68,205 $— $— $68,205 
Liabilities:
Contingent consideration$— $— $10,840 $10,840 
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The following table presents a summary of the changes in the fair value of our contingent consideration liabilities measured using Level 3 inputs during the three and nine months ended September 30, 2026 and 2025:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(in thousands)
Beginning balance$— $10,310 $10,840 $14,050 
Payments— — (10,537)(5,358)
Net (gains) losses recognized— 1,880 (303)3,498 
Ending balance$— $12,190 $— $12,190 
v3.26.3
Accrued Liabilities and Other (Tables)
 9 Months Ended
Sep. 30, 2026
Payables and Accruals [Abstract]  
Schedule of Accrued Liabilities
Accrued and other current liabilities were as follows:
September 30,December 31,
20262025
(in thousands)
Payroll-related accruals$21,001 $28,572 
Value-added and other tax5,040 7,857 
Purchasing accruals4,834 3,998 
Accrued interest expense2,900 2,659 
Accrued professional fees2,354 2,143 
Accrued royalties3,389 3,462 
Consideration payable in cash or equity— 120 
Accrued restructuring2,150 — 
Accrued other liabilities7,359 6,472 
Total accrued liabilities and other$49,027 $55,283 
v3.26.3
Debt (Tables)
 9 Months Ended
Sep. 30, 2026
Debt Disclosure [Abstract]  
Schedule of debt
The following table summarizes information relating to our outstanding debt as of September 30, 2026 and December 31, 2025:
As of September 30, 2026As of December 31, 2025
Amount OutstandingEffective RateAmount OutstandingEffective Rate
(in thousands, except interest rates)
Term loan facility$397,000 6.51 %$400,000 6.59 %
Revolving credit facility— — %— — %
Total principal amount397,000 400,000 
Unamortized discount and debt issuance costs(5,443)(6,127)
Total debt, net391,557 393,873 
Less: Current debt obligation(4,000)(4,000)
Long-term debt, net of current portion$387,557 $389,873 
Schedule of maturities of long-term debt
The following table summarizes the remaining future minimum principal payments under the Credit Agreement as of September 30, 2026:
(in thousands)
2026$1,000 
20274,000 
20284,000 
20294,000 
Thereafter384,000 
Total minimum principal payments$397,000 
v3.26.3
Earnings Per Share (Tables)
 9 Months Ended
Sep. 30, 2026
Earnings Per Share [Abstract]  
Schedule of Reconciliation of Shares In Basic And Diluted Earnings Per Share Calculation
A reconciliation of the number of shares in the calculation of basic and diluted earnings per share follows:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(in thousands)
Basic earnings per share
Numerator:
Net income (loss)$(4,373)$914 $(4,296)$(10,938)
Denominator:
Weighted-average common shares outstanding used in computing basic earnings per share186,087 187,599 187,408 188,213 
Basic earnings per share$(0.02)$0.00 $(0.02)$(0.06)
Diluted earnings per share
Numerator:
Net income (loss)$(4,373)$914 $(4,296)$(10,938)
Denominator:
Weighted-average shares used in computing basic earnings per share186,087 187,599 187,408 188,213 
Add dilutive impact of employee equity plans— 821 — — 
Weighted-average shares used in computing diluted earnings per share186,087 188,420 187,408 188,213 
Diluted earnings per share$(0.02)$0.00 $(0.02)$(0.06)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of the diluted net income per share attributable to common stockholders for the three months ended September 30, 2025, because their effect would have been anti-dilutive or for which the performance condition had not been met at the end of the period:
Three Months Ended September 30,
2025
(in thousands)
Restricted stock units8,055 
Total anti-dilutive shares8,055 
v3.26.3
Operating Segments and Geographic Information (Tables)
 9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Schedule of Revenue by Geographic Area The following tables set forth revenue by geographic area:
Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
(in thousands)
Revenue
United States, country of domicile$66,523 $64,579 $197,459 $189,230 
United Kingdom14,478 13,405 42,592 38,743 
All other international56,450 53,074 167,992 151,694 
Total revenue$137,451 $131,058 $408,043 $379,667 
Schedule of Long-lived Assets by Geographic Area The following tables set forth net long-lived assets by geographic area:
September 30,December 31,
20262025
(in thousands)
Long-lived assets, net
United States, country of domicile$13,752 $11,686 
Switzerland11,430 12,265 
United Kingdom8,843 5,724 
All other international9,026 8,717 
Total long-lived assets, net$43,051 $38,392 
v3.26.3
Restructuring (Tables)
 9 Months Ended
Sep. 30, 2026
Restructuring and Related Activities [Abstract]  
Restructuring and Related Costs
The following table summarizes activity in our restructuring liability related to the 2026 Reorganization, which is included in “accrued liabilities and other” in our Consolidated Balance Sheets.
(in thousands)
Balance as of December 31, 2025$— 
Costs incurred and charged to expense4,866 
Cash payments(2,706)
Effect of foreign currency exchange rates(10)
Balance as of September 30, 2026$2,150 
v3.26.3
Summary of Significant Accounting Policies - Statements of Balance Sheet (Details) - USD ($)
$ in Thousands
Sep. 30, 2026
Jun. 30, 2026
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Dec. 31, 2024
Current assets:            
Accounts receivable, net of allowance $ 45,155   $ 49,972 $ 44,577    
Current contract assets 16,092   19,528 22,883    
Total current assets 187,128   216,070 200,023    
Property and equipment, net 43,051   38,392 39,494    
Total assets 1,363,332   1,409,718 1,398,234    
Current liabilities:            
Accrued liabilities and other 49,027   55,283 49,524    
Income taxes payable 9,351   9,986 11,087    
Current portion of deferred revenue 20,468   27,207 18,759    
Total current liabilities 168,974   184,238 160,517    
Total liabilities 595,070   607,674 586,821    
Accumulated other comprehensive income 15,569   32,514 32,648    
Retained earnings 48,445   52,741 60,618    
Total stockholders' equity 768,262 $ 804,628 802,044 811,413 $ 807,937 $ 759,556
Total liabilities and stockholders' equity 1,363,332   1,409,718 1,398,234    
Allowance on accounts receivable $ 3,879   $ 4,059 3,328    
As Previously Reported            
Current assets:            
Accounts receivable, net of allowance       44,947    
Current contract assets       22,836    
Total current assets       200,346    
Property and equipment, net       38,989    
Total assets       1,398,052    
Current liabilities:            
Accrued liabilities and other       49,997    
Income taxes payable       10,118    
Current portion of deferred revenue       17,100    
Total current liabilities       158,362    
Total liabilities       584,666    
Accumulated other comprehensive income       33,836    
Retained earnings       61,403    
Total stockholders' equity       813,386    
Total liabilities and stockholders' equity       1,398,052    
Adjustments            
Current assets:            
Accounts receivable, net of allowance       (370)    
Current contract assets       47    
Total current assets       (323)    
Property and equipment, net       505    
Total assets       182    
Current liabilities:            
Accrued liabilities and other       (473)    
Income taxes payable       969    
Current portion of deferred revenue       1,659    
Total current liabilities       2,155    
Total liabilities       2,155    
Accumulated other comprehensive income       (1,188)    
Retained earnings       (785)    
Total stockholders' equity       (1,973)    
Total liabilities and stockholders' equity       $ 182    
v3.26.3
Summary of Significant Accounting Policies - Statements of Operations and Comprehensive Income (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue:        
Subscription and other revenue $ 137,451 $ 131,058 $ 408,043 $ 379,667
Cost of revenue:        
Cost of revenue 30,322 25,490 85,708 73,598
Total cost of revenue 34,554 29,730 98,418 86,234
Gross profit 102,897 101,328 309,625 293,433
Operating expenses:        
Total operating expenses 87,498 90,461 266,691 271,586
Operating income 15,399 10,867 42,934 21,847
Other expense, net:        
Other (expense) income, net 183 4,950 (913) 5,643
Total other expense, net (7,874) (3,681) (24,902) (18,149)
Income before income taxes 7,525 7,186 18,032 3,698
Income tax expense 11,898 6,272 22,328 14,636
Net (loss) income (4,373) 914 (4,296) (10,938)
Other comprehensive (loss) income:        
Foreign currency translation adjustment (2,100) 1,175 (16,945) 53,827
Other comprehensive (loss) income (2,100) 1,175 (16,945) 53,827
Comprehensive (loss) income $ (6,473) $ 2,089 $ (21,241) $ 42,889
Net income (loss) per share:        
Basic income (loss) per share (in dollars per share) $ (0.02) $ 0.00 $ (0.02) $ (0.06)
Diluted earnings per share (in dollars per share) $ (0.02) $ 0.00 $ (0.02) $ (0.06)
As Previously Reported        
Revenue:        
Subscription and other revenue   $ 131,710   $ 381,156
Cost of revenue:        
Cost of revenue   25,409   73,388
Total cost of revenue   29,649   86,024
Gross profit   102,061   295,132
Operating expenses:        
Total operating expenses   90,461   271,586
Operating income   11,600   23,546
Other expense, net:        
Other (expense) income, net   4,793   5,324
Total other expense, net   (3,838)   (18,468)
Income before income taxes   7,762   5,078
Income tax expense   6,379   14,879
Net (loss) income   1,383   (9,801)
Other comprehensive (loss) income:        
Foreign currency translation adjustment   1,199   54,931
Other comprehensive (loss) income   1,199   54,931
Comprehensive (loss) income   $ 2,582   $ 45,130
Net income (loss) per share:        
Basic income (loss) per share (in dollars per share)   $ 0.01   $ (0.05)
Diluted earnings per share (in dollars per share)   $ 0.01   $ (0.05)
Adjustments        
Revenue:        
Subscription and other revenue   $ (652)   $ (1,489)
Cost of revenue:        
Cost of revenue   81   210
Total cost of revenue   81   210
Gross profit   (733)   (1,699)
Operating expenses:        
Total operating expenses   0   0
Operating income   (733)   (1,699)
Other expense, net:        
Other (expense) income, net   157   319
Total other expense, net   157   319
Income before income taxes   (576)   (1,380)
Income tax expense   (107)   (243)
Net (loss) income   (469)   (1,137)
Other comprehensive (loss) income:        
Foreign currency translation adjustment   (24)   (1,104)
Other comprehensive (loss) income   (24)   (1,104)
Comprehensive (loss) income   $ (493)   $ (2,241)
Net income (loss) per share:        
Basic income (loss) per share (in dollars per share)   $ 0.00   $ (0.01)
Diluted earnings per share (in dollars per share)   $ 0.00   $ (0.01)
v3.26.3
Summary of Significant Accounting Policies - Statements of Cash Flow (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities        
Net (loss) income $ (4,373) $ 914 $ (4,296) $ (10,938)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:        
Depreciation and amortization     32,927 32,572
Loss (gain) on asset disposal       (319)
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in business combinations:        
Current contract assets     3,436 (9,909)
Income taxes payable     (462) 442
Deferred revenue     (8,206) (4,273)
Net cash provided by operating activities     $ 72,785 67,866
As Previously Reported        
Cash flows from operating activities        
Net (loss) income   1,383   (9,801)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:        
Depreciation and amortization       32,362
Loss (gain) on asset disposal       0
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in business combinations:        
Current contract assets       (10,050)
Income taxes payable       685
Deferred revenue       (5,621)
Net cash provided by operating activities       67,866
Adjustments        
Cash flows from operating activities        
Net (loss) income   $ (469)   (1,137)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:        
Depreciation and amortization       210
Loss (gain) on asset disposal       (319)
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in business combinations:        
Current contract assets       141
Income taxes payable       (243)
Deferred revenue       1,348
Net cash provided by operating activities       $ 0
v3.26.3
Summary of Significant Accounting Policies - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Money market funds $ 47,145   $ 47,145   $ 68,205
Revenue, advance billing period     12 months    
Current contract assets 16,092 $ 22,883 $ 16,092 $ 22,883 19,528
Noncurrent contract assets 600   600   2,400
Capitalized contract cost, net, current 3,200   3,200   2,700
Capitalized contract cost, net, noncurrent 2,000   $ 2,000   2,300
Amortization life (in years)     3 years    
Capitalized contract cost, amortization $ 800 $ 500 $ 2,200 $ 1,400  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-10-01          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 3 months   3 months    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-10-01          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period 2 years   2 years    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2029-10-01          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period      
Money market funds          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Money market funds $ 47,100   $ 47,100   $ 68,200
v3.26.3
Summary of Significant Accounting Policies - Changes in Accumulated Other Comprehensive Income (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance at beginning of period $ 804,628 $ 807,937 $ 802,044 $ 759,556
Other comprehensive loss before reclassification     (16,945)  
Amount reclassified from accumulated other comprehensive income     0  
Other comprehensive (loss) income (2,100) 1,175 (16,945) 53,827
Balance at end of period 768,262 811,413 768,262 811,413
Foreign Currency Translation Adjustments        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance at beginning of period     32,514  
Other comprehensive loss before reclassification     (16,945)  
Amount reclassified from accumulated other comprehensive income     0  
Other comprehensive (loss) income     (16,945)  
Balance at end of period 15,569   15,569  
Accumulated Other Comprehensive Income        
AOCI Attributable to Parent, Net of Tax [Roll Forward]        
Balance at beginning of period 17,669 31,473 32,514 (21,179)
Balance at end of period $ 15,569 $ 32,648 $ 15,569 $ 32,648
v3.26.3
Summary of Significant Accounting Policies - Revenue Disaggregation (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Disaggregation of Revenue [Line Items]        
Total revenue $ 137,451 $ 131,058 $ 408,043 $ 379,667
Revenue recognized at a point in time        
Disaggregation of Revenue [Line Items]        
Total revenue 8,886 13,071 28,544 39,902
Revenue recognized over time        
Disaggregation of Revenue [Line Items]        
Total revenue 128,565 117,987 379,499 339,765
Subscription revenue        
Disaggregation of Revenue [Line Items]        
Total revenue 136,343 129,865 404,567 375,751
Other revenue        
Disaggregation of Revenue [Line Items]        
Total revenue $ 1,108 $ 1,193 $ 3,476 $ 3,916
v3.26.3
Summary of Significant Accounting Policies - Changes in Deferred Revenue (Details)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
USD ($)
Movement in Deferred Revenue [Roll Forward]  
Balance as of December 31, 2025 $ 28,954
Deferred revenue recognized (26,641)
Additional amounts deferred 18,598
Balance as of September 30, 2026 $ 20,911
v3.26.3
Summary of Significant Accounting Policies - Expected Recognition of Deferred Revenue (Details)
$ in Thousands
Sep. 30, 2026
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected recognition of remaining performance obligations $ 267,169
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-10-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected recognition of remaining performance obligations 200,371
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-10-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected recognition of remaining performance obligations 66,371
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2029-10-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Expected recognition of remaining performance obligations $ 427
v3.26.3
Summary of Significant Accounting Policies - Cost of Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Product Information [Line Items]        
Amortization of acquired technologies $ 4,232 $ 4,240 $ 12,710 $ 12,636
Subscription and other revenue        
Product Information [Line Items]        
Amortization of acquired technologies $ 4,232 $ 4,240 $ 12,710 $ 12,636
v3.26.3
Acquisitions - Narrative (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jul. 29, 2026
Jun. 30, 2025
Nov. 20, 2024
Jun. 30, 2025
Sep. 30, 2026
Jun. 30, 2026
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Business Combination [Line Items]                    
Contingent consideration         $ 0   $ 0   $ 10,840  
Payments for debt issuance costs             10,537 $ 5,358    
Change in contingent liability             $ 303 $ (3,498)    
Infrascale Inc                    
Business Combination [Line Items]                    
Asset acquisition, consideration transferred $ 3,000                  
Contingent consideration period 36 months                  
Asset acquisition contingent consideration payout (as a percent) 100.00%                  
Contingent consideration $ 6,000                  
Converted APR (as a percent) 125.00%                  
Intangible asset, finite-lived, useful life         36 months   36 months      
Intangible asset amortization expense         $ 200   $ 200      
Infrascale Inc | Customer relationships                    
Business Combination [Line Items]                    
Fair value         3,000          
Adlumin, Inc.                    
Business Combination [Line Items]                    
Contingent consideration     $ 98,700              
Issuance of common stock (in shares)     1,570,762              
Additional payments     $ 120,000           105,200  
Contingent consideration maximum     30,000           15,000 $ 15,000
Contingent consideration deferred     96,300   65,700   65,700      
Contingent consideration deferred, net of payments         51,700   51,700      
Change in amount of contingent consideration, deferred         1,700   5,000      
General and administrative expense         900   2,600      
Interest expense         800   2,400      
Contingent consideration     16,600   $ 10,500   10,500      
Payments for debt issuance costs       $ 5,400   $ 10,500        
Change in contingent liability             $ 300      
Adlumin, Inc. | First anniversary                    
Business Combination [Line Items]                    
Additional payments   $ 45,500 52,500           45,500  
Deferred consideration liabilities     7,000              
Payments to acquire businesses, gross                 6,200  
Adlumin, Inc. | Second anniversary                    
Business Combination [Line Items]                    
Additional payments     67,500           $ 59,700  
Deferred consideration liabilities     $ 7,800              
v3.26.3
Acquisitions - Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Nov. 20, 2024
Business Combination [Line Items]      
Goodwill $ 1,010,761 $ 1,024,300  
Adlumin, Inc.      
Business Combination [Line Items]      
Current liabilities, net, including cash acquired of $52     $ (9,071)
Cash acquired     52
Property and equipment, net     182
Non-current liabilities, net     (4,754)
Goodwill     160,498
Total assets acquired, net     227,355
Adlumin, Inc. | Developed technology      
Business Combination [Line Items]      
Identifiable intangible assets     74,800
Adlumin, Inc. | Customer relationships      
Business Combination [Line Items]      
Identifiable intangible assets     5,400
Adlumin, Inc. | Trademarks      
Business Combination [Line Items]      
Identifiable intangible assets     $ 300
v3.26.3
Goodwill (Details)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
USD ($)
Goodwill [Roll Forward]  
Balance at beginning of period $ 1,024,300
Acquisitions 0
Foreign currency translation and other adjustments (13,539)
Balance at end of period $ 1,010,761
v3.26.3
Relationship with Parent and Related Entities (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2023
Related Party Transaction [Line Items]            
Related party transaction, term     2 years   2 years 2 years
Subscription and other revenue $ 137,451,000 $ 131,058,000 $ 408,043,000 $ 379,667,000    
Total operating expenses 87,498,000 90,461,000 266,691,000 271,586,000    
Related Party | SolarWinds Holdings, Inc. | Tax Matters Agreement            
Related Party Transaction [Line Items]            
Interest costs incurred 0 0 0 0    
Related Party | SolarWinds Holdings, Inc. | Software OEM agreements            
Related Party Transaction [Line Items]            
Subscription and other revenue 600,000 600,000 1,600,000 1,500,000    
Total operating expenses 0 100,000 100,000 200,000    
Related Party | SolarWinds Holdings, Inc. | Employee Matters Agreement            
Related Party Transaction [Line Items]            
Interest costs incurred 0 0 0 0    
Related Party | SolarWinds Holdings, Inc. | Intellectual Property Matters Agreement            
Related Party Transaction [Line Items]            
Interest costs incurred 0 0 0 0    
Related Party | SolarWinds Holdings, Inc. | Trademark License Agreement            
Related Party Transaction [Line Items]            
Interest costs incurred 0 0 0 0    
Related Party | SolarWinds Holdings, Inc. | Software cross license agreement            
Related Party Transaction [Line Items]            
Subscription and other revenue 0 0 0 0    
Total operating expenses 0 0 0 0    
Related Party | SolarWinds Holdings, Inc. | Sublease Agreement            
Related Party Transaction [Line Items]            
Total operating expenses 200,000 200,000 500,000 500,000    
Equity-based incentive plan | Related Party | SolarWinds Holdings, Inc.            
Related Party Transaction [Line Items]            
Conversion incremental compensation expense $ 0 $ 0 $ 0 $ 100,000    
Minimum | Equity-based incentive plan | Related Party            
Related Party Transaction [Line Items]            
Award vesting period     1 year      
Maximum | Equity-based incentive plan | Related Party            
Related Party Transaction [Line Items]            
Award vesting period     5 years      
v3.26.3
Fair Value Measurements - Schedule of Fair Value of Financial Assets Measured on a Recurring Basis (Details) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market funds $ 47,145 $ 68,205
Contingent consideration 0 10,840
Quoted Prices in Active Markets for Identical Assets (Level 1)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market funds 47,145 68,205
Contingent consideration 0 0
Significant Other Observable Inputs (Level 2)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market funds 0 0
Contingent consideration 0 0
Significant Unobservable Inputs (Level 3)    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Money market funds 0 0
Contingent consideration $ 0 $ 10,840
v3.26.3
Fair Value Measurements - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Payments $ 0 $ 0 $ (10,537) $ (5,358)
Significant Unobservable Inputs (Level 3)        
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Beginning balance 0 10,310 10,840 14,050
Net (gains) losses recognized 0 1,880 (303) 3,498
Ending balance $ 0 $ 12,190 $ 0 $ 12,190
v3.26.3
Accrued Liabilities and Other (Details) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Sep. 30, 2025
Payables and Accruals [Abstract]      
Payroll-related accruals $ 21,001 $ 28,572  
Value-added and other tax 5,040 7,857  
Purchasing accruals 4,834 3,998  
Accrued interest expense 2,900 2,659  
Accrued professional fees 2,354 2,143  
Accrued royalties 3,389 3,462  
Consideration payable in cash or equity 0 120  
Accrued restructuring 2,150 0  
Accrued other liabilities 7,359 6,472  
Accrued liabilities and other $ 49,027 $ 55,283 $ 49,524
v3.26.3
Debt - Narrative (Details)
 9 Months Ended
Jul. 19, 2021
USD ($)
Sep. 30, 2026
USD ($)
payment
Jun. 16, 2026
USD ($)
Dec. 31, 2025
USD ($)
Nov. 26, 2025
USD ($)
Nov. 25, 2025
USD ($)
Debt Instrument [Line Items]            
Unamortized discount and debt issuance costs   $ (5,443,000)   $ (6,127,000)    
Current debt obligation   5,176,000   4,000,000    
Current maturities of long term debt   $ 4,000,000   $ 4,000,000    
Credit agreement            
Debt Instrument [Line Items]            
Maximum borrowing capacity $ 410,000,000.0          
Unamortized discount and debt issuance costs         $ 4,100,000  
Credit agreement | Secured debt            
Debt Instrument [Line Items]            
Face amount of debt 350,000,000.0          
Payments of line of credit proceeds to former parent 16,500,000          
Quarterly periodic payment, as a percentage of original principal   0.25%        
Credit agreement | Revolving credit facility | Line of credit            
Debt Instrument [Line Items]            
Maximum borrowing capacity $ 60,000,000.0       60,000,000.0  
Covenant, leverage ratio, maximum   7.50        
Commitment fee percentage   0.375%        
Covenant, commitment fee percentage, net leverage ratio, reduction per annum   0.25%        
Covenant, borrowing percentage of commitments, maximum   40.00%        
Credit Agreement. Amendment No. 2 | Secured debt            
Debt Instrument [Line Items]            
Basis spread on variable rate   2.75%        
Credit Agreement. Amendment No. 2 | Secured debt | LIBOR            
Debt Instrument [Line Items]            
Variable rate floor   0.00%        
Credit Agreement. Amendment No. 2 | Revolving credit facility | Line of credit            
Debt Instrument [Line Items]            
Debt instrument, margin increase based on net leverage ratio   2.75%        
Covenant, leverage ratio, maximum   2.50        
Margin is subject to reductions based on our first lien net leverage ratio, percentage   2.50%        
Covenant, leverage ratio, minimum   1.65        
Credit Agreement. Amendment No. 2 | Revolving credit facility | Line of credit | LIBOR            
Debt Instrument [Line Items]            
Variable rate floor   0.00%        
Basis spread on variable rate   2.50%        
Credit Agreement. Amendment No. 2 | Revolving credit facility | Line of credit | Eurodollar            
Debt Instrument [Line Items]            
Variable rate floor   0.00%        
Credit Agreement. Amendment No. 2 | Revolving credit facility | Term Loan            
Debt Instrument [Line Items]            
Maximum borrowing capacity         $ 400,000,000.0 $ 336,000,000.0
Delayed Draw Term Loan            
Debt Instrument [Line Items]            
Maximum borrowing capacity     $ 100,000      
Minimum funding amount     1,000,000.0      
Allowable remaining amount   $ 0        
Loan commitment asset   2,300,000        
Delayed Draw Term Loan | Line of credit            
Debt Instrument [Line Items]            
Face amount of debt     $ 75,000,000.0      
Insurance Premium Financing            
Debt Instrument [Line Items]            
Face amount of debt   $ 1,400,000        
Debt instrument, interest rate, stated percentage   6.25%        
Number of payments | payment   11        
Current debt obligation   $ 1,200,000        
v3.26.3
Debt - Schedule of Debt (Details) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Nov. 26, 2025
Debt Instrument [Line Items]      
Total principal amount $ 397,000 $ 400,000  
Unamortized discount and debt issuance costs (5,443) (6,127)  
Total debt, net 391,557 393,873  
Less: Current debt obligation (4,000) (4,000)  
Long-term debt, net of current portion 387,557 389,873  
Credit agreement      
Debt Instrument [Line Items]      
Unamortized discount and debt issuance costs     $ 4,100
Secured debt | Credit agreement      
Debt Instrument [Line Items]      
Total principal amount $ 397,000 $ 400,000  
Effective Rate 6.51% 6.59%  
Total debt, net $ 397,000    
Line of credit | Revolving credit facility | Credit agreement      
Debt Instrument [Line Items]      
Total principal amount $ 0 $ 0  
Effective Rate 0.00% 0.00%  
v3.26.3
Debt - Schedule of Future Minimum Principal Payments of Debt (Details) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Debt Instrument [Line Items]    
Total debt, net $ 391,557 $ 393,873
Credit agreement | Secured debt    
Debt Instrument [Line Items]    
2026 1,000  
2027 4,000  
2028 4,000  
2029 4,000  
Thereafter 384,000  
Total debt, net $ 397,000  
v3.26.3
Earnings Per Share - Schedule of Reconciliation of Shares in the Calculation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Numerator:        
Net income (loss) $ (4,373) $ 914 $ (4,296) $ (10,938)
Weighted-average common shares outstanding used in computing basic earnings per share (in shares) 186,087 187,599 187,408 188,213
Basic earnings per share (in dollars per share) $ (0.02) $ 0.00 $ (0.02) $ (0.06)
Diluted earnings per share        
Net income (loss) $ (4,373) $ 914 $ (4,296) $ (10,938)
Weighted-average shares used in computing basic earnings per share (in shares) 186,087 187,599 187,408 188,213
Add dilutive impact of employee equity plans (in shares) 0 821 0 0
Weighted-average shares used in computing diluted earnings per share (in shares) 186,087 188,420 187,408 188,213
Diluted earnings per share (in dollars per share) $ (0.02) $ 0.00 $ (0.02) $ (0.06)
v3.26.3
Earnings Per Share - Schedule of Weighted Average Outstanding Shares of Common Stock Equivalents Excluded (Details)
shares in Thousands
 3 Months Ended
Sep. 30, 2025
shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Total anti-dilutive shares (in shares) 8,055
Restricted Stock Units (RSUs)  
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]  
Total anti-dilutive shares (in shares) 8,055
v3.26.3
Earnings Per Share - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 12 Months Ended
Sep. 30, 2026
Dec. 31, 2025
Aug. 26, 2026
Mar. 11, 2025
Earnings Per Share [Abstract]        
Share repurchase program authorized amount     $ 125.0 $ 75.0
Common stock, par or stated value per share (in dollars per share) $ 0.001 $ 0.001   $ 0.001
Share repurchase program authorized amount of increase     $ 50.0  
Repurchase of stock (in shares) 10,184,738 3,776,155    
Repurchase of common stock $ 38.7 $ 30.0    
Remaining authorized under stock repurchase plan $ 56.3      
v3.26.3
Income Taxes (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Tax Disclosure [Abstract]        
Income tax expense $ 11,898 $ 6,272 $ 22,328 $ 14,636
Effective income tax rate 158.10% 87.30% 123.80% 395.80%
Discrete income tax expense $ 6,700   $ 6,700  
v3.26.3
Operating Segments and Geographic Information - Narrative (Details)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2026
USD ($)
segment
Sep. 30, 2025
USD ($)
Segment Reporting [Line Items]        
Number of operating segments | segment     1  
Number of reportable segments | segment     1  
Reportable Segment        
Segment Reporting [Line Items]        
Depreciation | $ $ 4.0 $ 4.8 $ 12.7 $ 13.7
Amortization | $ $ 6.9 $ 6.4 $ 20.2 $ 18.8
v3.26.3
Operating Segments and Geographic Information - Schedule of Revenue by Geographic Area (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]        
Total revenue $ 137,451 $ 131,058 $ 408,043 $ 379,667
United States, country of domicile        
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]        
Total revenue 66,523 64,579 197,459 189,230
United Kingdom        
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]        
Total revenue 14,478 13,405 42,592 38,743
All other international        
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]        
Total revenue $ 56,450 $ 53,074 $ 167,992 $ 151,694
v3.26.3
Operating Segments and Geographic Information - Schedule of Long-lived Assets by Geographic Area (Details) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]    
Total long-lived assets, net $ 43,051 $ 38,392
United States, country of domicile    
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]    
Total long-lived assets, net 13,752 11,686
Switzerland    
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]    
Total long-lived assets, net 11,430 12,265
United Kingdom    
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]    
Total long-lived assets, net 8,843 5,724
All other international    
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items]    
Total long-lived assets, net $ 9,026 $ 8,717
v3.26.3
Restructuring - Narrative (Details)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2026
USD ($)
Sep. 30, 2026
USD ($)
Jul. 20, 2026
USD ($)
Restructuring Cost and Reserve [Line Items]      
Number of positions eliminated (as a percent)     0.06
Severance costs $ 4.9 $ 4.9  
Income Statement Location [Axis]: us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization      
Restructuring Cost and Reserve [Line Items]      
Severance costs 0.3 0.3  
Income Statement Location [Axis]: us-gaap:GeneralAndAdministrativeExpense      
Restructuring Cost and Reserve [Line Items]      
Severance costs 0.1 0.1  
Income Statement Location [Axis]: us-gaap:ResearchAndDevelopmentExpense      
Restructuring Cost and Reserve [Line Items]      
Severance costs 2.2 2.2  
Income Statement Location [Axis]: us-gaap:SellingAndMarketingExpense      
Restructuring Cost and Reserve [Line Items]      
Severance costs $ 2.3 $ 2.3  
Maximum      
Restructuring Cost and Reserve [Line Items]      
Expected restructuring cost     $ 6.0
Minimum      
Restructuring Cost and Reserve [Line Items]      
Expected restructuring cost     $ 5.0
v3.26.3
Restructuring - Schedule Of Accrued Liabilities And Other (Details)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
USD ($)
Restructuring Reserve [Roll Forward]  
Balance as of December 31, 2025 $ 0
Restructuring charges 4,866
Cash payments (2,706)
Effect of foreign currency exchange rates (10)
Balance as of September 30, 2026 $ 2,150
v3.26.3
Subsequent Events (Details) - USD ($)
$ in Thousands
 9 Months Ended
Oct. 08, 2026
Sep. 30, 2026
Sep. 30, 2025
Jun. 16, 2026
Subsequent Event [Line Items]        
Payments of debt issuance costs   $ 2,298 $ 0  
Delayed Draw Term Loan        
Subsequent Event [Line Items]        
Maximum borrowing capacity       $ 100
Delayed Draw Term Loan | Subsequent Event        
Subsequent Event [Line Items]        
Maximum borrowing capacity $ 75,000      
Net proceeds 73,400      
Payments of debt issuance costs 700      
Line of credit facility, commitment fee amount $ 900